Linezolid (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Linezolid" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

104nih.gov

4^th place

8^th place

84worldcat.org

5^th place

10^th place

81doi.org

2^nd place

5^th place

18web.archive.org

1^st place

2^nd place

12oxfordjournals.org

1,389^th place

362^nd place

11asm.org

3,555^th place

888^th place

10archive.org

6^th place

9^th place

3fda.gov

447^th place

409^th place

2books.google.com

3^rd place

11^th place

2medscape.com

719^th place

152^nd place

2york.ac.uk

7,670^th place

9,092^nd place

1merck.com

6,464^th place

295^th place

1annals.org

low place

1,130^th place

1anvisa.gov.br

low place

1medicines.org.uk

3,823^rd place

3,244^th place

1docguide.com

low place

1prnewswire.ca

low place

1medicalnewstoday.com

3,011^th place

965^th place

1rib-x.com

low place

1hpa.org.uk

low place

6,924^th place

1infezmed.it

low place

1theage.com.au

412^th place

1,605^th place

1elsevier.es

7,063^rd place

low place

1brit-thoracic.org.uk

low place

1atsjournals.org

low place

7,298^th place

1biomedcentral.com

2,747^th place

2,635^th place

1amebis.si

low place

43^rd place

1bmj.com

1,226^th place

862^nd place

1europa.eu

68^th place

28^th place

1imm.ac.cn

low place

1abf.org.br

low place

1espacenet.com

800^th place

1,852^nd place

1confex.com

6,094^th place

1,676^th place

1aafp.org

1,916^th place

382^nd place

1aspetjournals.org

6,663^rd place

2,107^th place

1virginia.edu

1,041^st place

1,491^st place

1jbc.org

4,455^th place

898^th place

1pnas.org

1,293^rd place

373^rd place

aafp.org

Ament PW; Jamshed N; Horne JP (2002). »Linezolid: its role in the treatment of gram-positive, drug-resistant bacterial infections«. American Family Physician. 65 (4): 663–670. ISSN 0002-838X. PMID 11871684. Arhivirano iz prvotnega spletišča dne 24. julija 2008. Pridobljeno 2. oktobra 2010.

abf.org.br

Kaiser CR; Cunico W; Pinheiro AC; Oliveira AG; Peralta MA; Souza MV (2007). »Oxazolidinones: a new class of compounds against tuberculosis« (PDF). Revista Brasileira de Farmácia (v portugalščini). 88 (2): 83–88. Arhivirano (PDF) iz spletišča dne 31. oktobra 2008. Pridobljeno 2. oktobra 2010.

amebis.si

lsm1.amebis.si

http://lsm1.amebis.si/lsmeds/novPogoj.aspx Arhivirano 2011-02-11 na Wayback Machine., vpogled: 18. 10. 2010.

annals.org

Moellering RC (2003). »Linezolid: the first oxazolidinone antimicrobial« (PDF). Annals of Internal Medicine. 138 (2): 135–142. ISSN 0003-4819. PMID 12529096.

anvisa.gov.br

ANVISA (5. junij 2000). »Resolução nº 474, de 5 de junho de 2000« (v portugalščini). National Health Surveillance Agency. Pridobljeno 19. maja 2009.

archive.org

Kalia V; Miglani R; Purnapatre KP; in sod. (2009). »Mode of action of Ranbezolid against staphylococci and structural modeling studies of its interaction with ribosomes«. Antimicrobial Agents and Chemotherapy. 53 (4): 1427–1433. doi:10.1128/AAC.00887-08. ISSN 0066-4804. PMC 2663096. PMID 19075051.
Jones RN; Stilwell MG; Hogan PA; Sheehan DJ (2007). »Activity of linezolid against 3,251 strains of uncommonly isolated gram-positive organisms: report from the SENTRY Antimicrobial Surveillance Program«. Antimicrobial Agents and Chemotherapy. 51 (4): 1491–1493. doi:10.1128/AAC.01496-06. PMC 1855453. PMID 17210770.
Jodlowski TZ; Melnychuk I; Conry J (2007). »Linezolid for the treatment of Nocardia spp. infections«. Annals of Pharmacotherapy. 41 (10): 1694–1699. doi:10.1345/aph.1K196. ISSN 1060-0280. PMID 17785610.
Vardakas KZ; Horianopoulou M; Falagas ME (2008). »Factors associated with treatment failure in patients with diabetic foot infections: An analysis of data from randomized controlled trials«. Diabetes Research and Clinical Practice. Zv. 80, št. 3. str. 344–351. doi:10.1016/j.diabres.2008.01.009. ISSN 0168-8227. PMID 18291550.
Ang JY; Lua JL; Turner DR; Asmar BI (2003). »Vancomycin-resistant Enterococcus faecium endocarditis in a premature infant successfully treated with linezolid«. The Pediatric Infectious Disease Journal. 22 (12): 1101–1103. doi:10.1097/01.inf.0000101784.83146.0c. ISSN 0891-3668. PMID 14688576.
Ntziora F; Falagas ME (2007). »Linezolid for the treatment of patients with central nervous system infection«. Annals of Pharmacotherapy. 41 (2): 296–308. doi:10.1345/aph.1H307. ISSN 1060-0280. PMID 17284501. Structured abstract with quality assessment available at DARE.
Narita M; Tsuji BT; Yu VL (2007). »Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome«. Pharmacotherapy. 27 (8): 1189–1197. doi:10.1592/phco.27.8.1189. ISSN 0277-0008. PMID 17655517.
Saijo T; Hayashi K; Yamada H; Wakakura M (2005). »Linezolid-induced optic neuropathy«. American Journal of Ophthalmology. 139 (6): 1114–1116. doi:10.1016/j.ajo.2004.11.047. ISSN 0002-9394. PMID 15953450.
Sisson TL; Jungbluth GL; Hopkins NK (2002). »Age and sex effects on the pharmacokinetics of linezolid«. European Journal of Clinical Pharmacology. 57 (11): 793–797. doi:10.1007/s00228-001-0380-y. ISSN 0031-6970. PMID 11868801.
Huang V; Gortney JS (2006). »Risk of serotonin syndrome with concomitant administration of linezolid and serotonin agonists«. Pharmacotherapy. 26 (12): 1784–93. doi:10.1592/phco.26.12.1784. ISSN 0277-0008. PMID 17125439.

asm.org

aac.asm.org

Slee AM; Wuonola MA; McRipley RJ; in sod. (1987). »Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721« (PDF). Antimicrobial Agents and Chemotherapy. 31 (11): 1791–1797. ISSN 0066-4804. PMC 175041. PMID 3435127. Arhivirano iz prvotnega spletišča (PDF) dne 11. junija 2011. Pridobljeno 2. oktobra 2010.
Karlowsky JA; Kelly LJ; Critchley IA; Jones ME; Thornsberry C; Sahm DF (2002). »Determining Linezolid's baseline in vitro activity in Canada using gram-positive clinical isolates collected prior to its national release«. Antimicrobial Agents and Chemotherapy. 46 (6): 1989–1992. doi:10.1128/AAC.46.6.1989-1992.2002. ISSN 0066-4804. PMC 127260. PMID 12019122.
Howe RA; Wootton M; Noel AR; Bowker KE; Walsh TR; MacGowan AP (2003). »Activity of AZD2563, a novel oxazolidinone, against Staphylococcus aureus strains with reduced susceptibility to vancomycin or linezolid«. Antimicrobial Agents and Chemotherapy. 47 (11): 3651–3652. doi:10.1128/AAC.47.11.3651-3652.2003. ISSN 0066-4804. PMC 253812. PMID 14576139.
Peláez T; Alonso R; Pérez C; Alcalá L; Cuevas O; Bouza E (2002). »In vitro activity of linezolid against Clostridium difficile«. Antimicrobial Agents and Chemotherapy. 46 (5): 1617–1618. doi:10.1128/AAC.46.5.1617-1618.2002. ISSN 0066-4804. PMC 127182. PMID 11959617.
McKee EE; Ferguson M; Bentley AT; Marks TA (2006). »Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones«. Antimicrobial Agents and Chemotherapy. 50 (6): 2042–2049. doi:10.1128/AAC.01411-05. ISSN 0066-4804. PMC 1479116. PMID 16723564.
Bishop E; Melvani S; Howden BP; Charles PG; Grayson ML (2006). »Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients«. Antimicrobial Agents and Chemotherapy. 50 (4): 1599–1602. doi:10.1128/AAC.50.4.1599-1602.2006. ISSN 0066-4804. PMC 1426936. PMID 16569895.
Skripkin E; McConnell TS; DeVito J; in sod. (2008). »Rχ-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance«. Antimicrobial Agents and Chemotherapy. 52 (10): 3550–3557. doi:10.1128/AAC.01193-07. ISSN 0066-4804. PMC 2565890. PMID 18663023.
Swaney SM; Aoki H; Ganoza MC; Shinabarger DL (1. december 1998). »The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria«. Antimicrobial Agents and Chemotherapy. 42 (12): 3251–3255. ISSN 0066-4804. PMC 106030. PMID 9835522. Arhivirano iz prvotnega spletišča dne 17. januarja 2011. Pridobljeno 2. oktobra 2010.
Scheetz MH; Knechtel SA; Malczynski M; Postelnick MJ; Qi C (2008). »Increasing incidence of linezolid-intermediate or -resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumption«. Antimicrobial Agents and Chemotherapy. 52 (6): 2256–2259. doi:10.1128/AAC.00070-08. ISSN 0066-4804. PMC 2415807. PMID 18391028.
Besier S; Ludwig A; Zander J; Brade V; Wichelhaus TA (2008). »Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances«. Antimicrobial Agents and Chemotherapy. 52 (4): 1570–1572. doi:10.1128/AAC.01098-07. ISSN 0066-4804. PMC 2292563. PMID 18212098.

jcm.asm.org

Tsigrelis C; Singh KV; Coutinho TD; Murray BE; Baddour LM (2007). »Vancomycin-resistant Enterococcus faecalis endocarditis: linezolid failure and strain characterization of virulence factors«. Journal of Clinical Microbiology. 45 (2): 631–635. doi:10.1128/JCM.02188-06. ISSN 0095-1137. PMC 1829077. PMID 17182759.

aspetjournals.org

dmd.aspetjournals.org

Slatter JG; Stalker DJ; Feenstra KL; in sod. (1. avgust 2001). »Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [¹⁴C]linezolid to healthy human subjects«. Drug Metabolism and Disposition. 29 (8): 1136–1145. ISSN 0090-9556. PMID 11454733. Arhivirano iz prvotnega spletišča dne 7. januarja 2009. Pridobljeno 2. oktobra 2010.

atsjournals.org

ajrccm.atsjournals.org

American Thoracic Society; Infectious Diseases Society of America (2005). »Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia«. American Journal of Respiratory and Critical Care Medicine. 171 (4): 388–416. doi:10.1164/rccm.200405-644ST. ISSN 1073-449X. PMID 15699079.

biomedcentral.com

Koya D; Shibuya K; Kikkawa R; Haneda M (2004). »Successful recovery of infective endocarditis-induced rapidly progressive glomerulonephritis by steroid therapy combined with antibiotics: a case report«. BMC Nephrology. 5 (1): 18. doi:10.1186/1471-2369-5-18. PMC 544880. PMID 15610562.

bmj.com

jnnp.bmj.com

Chao CC; Sun HY; Chang YC; Hsieh ST (2008). »Painful neuropathy with skin denervation after prolonged use of linezolid«. Journal of Neurology, Neurosurgery & Psychiatry. 79 (1): 97–99. doi:10.1136/jnnp.2007.127910. ISSN 0022-3050. PMID 17766431.

books.google.com

Brickner SJ (1996). »Oxazolidinone antibacterial agents«. Current Pharmaceutical Design. 2 (2): 175–194. Detailed review of the discovery and development of the whole oxazolidinone class, including information on synthesis and structure-activity relationships.
Davaro RE; Glew RH; Daly JS (2004). »Oxazolidinones, quinupristin-dalfopristin, and daptomycin«. V Gorbach SL; Bartlett JG; Blacklow NR (ur.). Infectious diseases. Hagerstown, MD: Lippincott Williams & Wilkins. str. 241–243. ISBN 0-7817-3371-5. Pridobljeno 20. junija 2009.

brit-thoracic.org.uk

BTS Pneumonia Guidelines Committee (30. april 2004). »BTS guidelines for the management of community acquired pneumonia in adults – 2004 update« (PDF). British Thoracic Society. Arhivirano iz prvotnega spletišča (PDF) dne 21. septembra 2008. Pridobljeno 30. junija 2009.

confex.com

acs.confex.com

Perrault WR, Keeler JB, Snyder WC, et al. (June 25, 2008). "Convergent green synthesis of linezolid (Zyvox)" Arhivirano 2011-07-28 na Wayback Machine., in 12th Annual Green Chemistry and Engineering Conference, 24.–26. junij 2008, New York, NY. Pridobljeno 8. 6. 2009.

docguide.com

»Canada Approves Marketing Of Zyvoxam (Linezolid) For Gram Positive Infections« (tiskovna objava). 8. maj 2001. Pridobljeno 18. maja 2009.

doi.org

Grau S; Rubio-Terrés C (2008). »Pharmacoeconomics of linezolid«. Expert Opinion on Pharmacotherapy. 9 (6): 987–1000. doi:10.1517/14656566.9.6.987. ISSN 1465-6566. PMID 18377341.
Livermore DM (2000). »Quinupristin/dalfopristin and linezolid: where, when, which and whether to use?«. Journal of Antimicrobial Chemotherapy. 46 (3): 347–50. doi:10.1093/jac/46.3.347. ISSN 0305-7453. PMID 10980159.
Barbachyn MR; Ford CW (2003). »Oxazolidinone structure-activity relationships leading to linezolid«. Angewandte Chemie (International Edition in English). 42 (18): 2010–2023. doi:10.1002/anie.200200528. ISSN 1433-7851. PMID 12746812.
French G (2003). »Safety and tolerability of linezolid«. Journal of Antimicrobial Chemotherapy. 51 (Suppl 2): ii45–53. doi:10.1093/jac/dkg253. ISSN 0305-7453. PMID 12730142. Review. Includes extensive discussion of the hematological adverse effects of linezolid.
Ford CW; Zurenko GE; Barbachyn MR (2001). »The discovery of linezolid, the first oxazolidinone antibacterial agent«. Current Drug Targets – Infectious Disorders. 1 (2): 181–199. doi:10.2174/1568005014606099. ISSN 1568-0053. PMID 12455414.
Irinoda K; Nomura S; Hashimoto M (2002). »Antimicrobial and clinical effect of linezolid (ZYVOX), new class of synthetic antibacterial drug«. Nippon Yakurigaku Zasshi (v japonščini). 120 (4): 245–252. doi:10.1254/fpj.120.245. ISSN 0015-5691. PMID 12425150.
Karlowsky JA; Kelly LJ; Critchley IA; Jones ME; Thornsberry C; Sahm DF (2002). »Determining Linezolid's baseline in vitro activity in Canada using gram-positive clinical isolates collected prior to its national release«. Antimicrobial Agents and Chemotherapy. 46 (6): 1989–1992. doi:10.1128/AAC.46.6.1989-1992.2002. ISSN 0066-4804. PMC 127260. PMID 12019122.
Livermore DM; Mushtaq S; Warner M; Woodford N (2009). »Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci«. Journal of Antimicrobial Chemotherapy. 63 (4): 713–715. doi:10.1093/jac/dkp002. ISSN 0305-7453. PMID 19164418.
Howe RA; Wootton M; Noel AR; Bowker KE; Walsh TR; MacGowan AP (2003). »Activity of AZD2563, a novel oxazolidinone, against Staphylococcus aureus strains with reduced susceptibility to vancomycin or linezolid«. Antimicrobial Agents and Chemotherapy. 47 (11): 3651–3652. doi:10.1128/AAC.47.11.3651-3652.2003. ISSN 0066-4804. PMC 253812. PMID 14576139.
Kalia V; Miglani R; Purnapatre KP; in sod. (2009). »Mode of action of Ranbezolid against staphylococci and structural modeling studies of its interaction with ribosomes«. Antimicrobial Agents and Chemotherapy. 53 (4): 1427–1433. doi:10.1128/AAC.00887-08. ISSN 0066-4804. PMC 2663096. PMID 19075051.
Jones RN; Stilwell MG; Hogan PA; Sheehan DJ (2007). »Activity of linezolid against 3,251 strains of uncommonly isolated gram-positive organisms: report from the SENTRY Antimicrobial Surveillance Program«. Antimicrobial Agents and Chemotherapy. 51 (4): 1491–1493. doi:10.1128/AAC.01496-06. PMC 1855453. PMID 17210770.
Jodlowski TZ; Melnychuk I; Conry J (2007). »Linezolid for the treatment of Nocardia spp. infections«. Annals of Pharmacotherapy. 41 (10): 1694–1699. doi:10.1345/aph.1K196. ISSN 1060-0280. PMID 17785610.
Herrmann DJ; Peppard WJ; Ledeboer NA; Theesfeld ML; Weigelt JA; Buechel BJ (2008). »Linezolid for the treatment of drug-resistant infections«. Expert Review of Anti-infective Therapy. 6 (6): 825–848. doi:10.1586/14787210.6.6.825. ISSN 1478-7210. PMID 19053895.
Geisler WM; Malhotra U; Stamm WE (2001). »Pneumonia and sepsis due to fluoroquinolone-resistant Capnocytophaga gingivalis after autologous stem cell transplantation«. Bone Marrow Transplantation. 28 (12): 1171–1173. doi:10.1038/sj.bmt.1703288. ISSN 0268-3369. PMID 11803363.
Wilson AP; Cepeda JA; Hayman S; Whitehouse T; Singer M; Bellingan G (2006). »In vitro susceptibility of Gram-positive pathogens to linezolid and teicoplanin and effect on outcome in critically ill patients«. Journal of Antimicrobial Chemotherapy. 58 (2): 470–3. doi:10.1093/jac/dkl233. ISSN 0305-7453. PMID 16735420.
Falagas ME; Siempos II; Vardakas KZ (2008). »Linezolid versus glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials«. Lancet Infectious Diseases. Zv. 8, št. 1. str. 53–66. doi:10.1016/S1473-3099(07)70312-2. ISSN 1473-3099. PMID 18156089. Strukturiran izvleček z oceno kakovosti dostopen v DARE.
Chow I; Lemos EV; Einarson TR (2008). »Management and prevention of diabetic foot ulcers and infections: a health economic review«. PharmacoEconomics. Zv. 26, št. 12. str. 1019–1035. doi:10.2165/0019053-200826120-00005. ISSN 1170-7690. PMID 19014203.
Lipsky BA; Itani K; Norden C (2004). »Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate«. Clinical Infectious Diseases. Zv. 38, št. 1. str. 17–24. doi:10.1086/380449. ISSN 1058-4838. PMID 14679443.
Pigrau C; Almirante B (2009). »[Oxazolidinones, glycopeptides and cyclic lipopeptides]«. Enfermedades Infecciosas y Microbiología Clínica (v španščini). Zv. 27, št. 4. str. 236–46. doi:10.1016/j.eimc.2009.02.004. PMID 19406516.^{[mrtva povezava]}
Vardakas KZ; Horianopoulou M; Falagas ME (2008). »Factors associated with treatment failure in patients with diabetic foot infections: An analysis of data from randomized controlled trials«. Diabetes Research and Clinical Practice. Zv. 80, št. 3. str. 344–351. doi:10.1016/j.diabres.2008.01.009. ISSN 0168-8227. PMID 18291550.
Grammatikos A; Falagas ME (2008). »Linezolid for the treatment of skin and soft tissue infection«. Expert Review of Dermatology. Zv. 3, št. 5. str. 539–548. doi:10.1586/17469872.3.5.539.
Mandell LA; Wunderink RG; Anzueto A; in sod. (2007). »Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults«. Clinical Infectious Diseases. 44 (Suppl 2): S27–72. doi:10.1086/511159. ISSN 1058-4838. PMID 17278083.
American Thoracic Society; Infectious Diseases Society of America (2005). »Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia«. American Journal of Respiratory and Critical Care Medicine. 171 (4): 388–416. doi:10.1164/rccm.200405-644ST. ISSN 1073-449X. PMID 15699079.
Koya D; Shibuya K; Kikkawa R; Haneda M (2004). »Successful recovery of infective endocarditis-induced rapidly progressive glomerulonephritis by steroid therapy combined with antibiotics: a case report«. BMC Nephrology. 5 (1): 18. doi:10.1186/1471-2369-5-18. PMC 544880. PMID 15610562.
Pankey GA; Sabath LD (2004). »Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections«. Clinical Infectious Diseases. 38 (6): 864–870. doi:10.1086/381972. ISSN 1058-4838. PMID 14999632.
Falagas ME; Manta KG; Ntziora F; Vardakas KZ (2006). »Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence«. Journal of Antimicrobial Chemotherapy. 58 (2): 273–280. doi:10.1093/jac/dkl219. ISSN 0305-7453. PMID 16735427.
Babcock HM; Ritchie DJ; Christiansen E; Starlin R; Little R; Stanley S (2001). »Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid«. Clinical Infectious Diseases. 32 (9): 1373–1375. doi:10.1086/319986. ISSN 1058-4838. PMID 11303275.
Ang JY; Lua JL; Turner DR; Asmar BI (2003). »Vancomycin-resistant Enterococcus faecium endocarditis in a premature infant successfully treated with linezolid«. The Pediatric Infectious Disease Journal. 22 (12): 1101–1103. doi:10.1097/01.inf.0000101784.83146.0c. ISSN 0891-3668. PMID 14688576.
Archuleta S; Murphy B; Keller MJ (2004). »Successful treatment of vancomycin-resistant Enterococcus faecium endocarditis with linezolid in a renal transplant recipient with human immunodeficiency virus infection«. Transplant Infectious Disease. 6 (3): 117–119. doi:10.1111/j.1399-3062.2004.00059.x. ISSN 1398-2273. PMID 15569227.
Zimmer SM; Caliendo AM; Thigpen MC; Somani J (2003). »Failure of linezolid treatment for enterococcal endocarditis«. Clinical Infectious Diseases. 37 (3): e29–30. doi:10.1086/375877. ISSN 1058-4838. PMID 12884185.
Tsigrelis C; Singh KV; Coutinho TD; Murray BE; Baddour LM (2007). »Vancomycin-resistant Enterococcus faecalis endocarditis: linezolid failure and strain characterization of virulence factors«. Journal of Clinical Microbiology. 45 (2): 631–635. doi:10.1128/JCM.02188-06. ISSN 0095-1137. PMC 1829077. PMID 17182759.
Berdal JE; Eskesen A (2008). »Short-term success, but long-term treatment failure with linezolid for enterococcal endocarditis«. Scandinavian Journal of Infectious Diseases. 40 (9): 765–766. doi:10.1080/00365540802087209. ISSN 0036-5548. PMID 18609208.
Falagas ME; Siempos II; Papagelopoulos PJ; Vardakas KZ (2007). »Linezolid for the treatment of adults with bone and joint infections«. International Journal of Antimicrobial Agents. 29 (3): 233–239. doi:10.1016/j.ijantimicag.2006.08.030. ISSN 0924-8579. PMID 17204407. Review.
Bassetti M; Vitale F; Melica G; in sod. (2005). »Linezolid in the treatment of Gram-positive prosthetic joint infections«. Journal of Antimicrobial Chemotherapy. 55 (3): 387–390. doi:10.1093/jac/dki016. ISSN 0305-7453. PMID 15705640.
Senneville E; Legout L; Valette M; in sod. (2006). »Effectiveness and tolerability of prolonged linezolid treatment for chronic osteomyelitis: a retrospective study«. Clinical Therapeutics. 28 (8): 1155–1163. doi:10.1016/j.clinthera.2006.08.001. ISSN 0149-2918. PMID 16982292.
Rao N; Hamilton CW (2007). »Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series«. Diagnostic Microbiology and Infectious Disease. 59 (2): 173–179. doi:10.1016/j.diagmicrobio.2007.04.006. ISSN 0732-8893. PMID 17574788.
von der Lippe B; Sandven P; Brubakk O (2006). »Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)—a report of ten cases«. Journal of Infection. 52 (2): 92–96. doi:10.1016/j.jinf.2005.04.007. ISSN 0163-4453. PMID 15907341.
Park IN; Hong SB; Oh YM; in sod. (2006). »Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis«. Journal of Antimicrobial Chemotherapy. 58 (3): 701–704. doi:10.1093/jac/dkl298. ISSN 0305-7453. PMID 16857689.
Fortún J; Martín-Dávila P; Navas E; in sod. (2005). »Linezolid for the treatment of multidrug-resistant tuberculosis«. Journal of Antimicrobial Chemotherapy. 56 (1): 180–5. doi:10.1093/jac/dki148. ISSN 0305-7453. PMID 15911549.
Jaksic B; Martinelli G; Perez-Oteyza J; Hartman CS; Leonard LB; Tack KJ (2006). »Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer«. Clinical Infectious Diseases. 42 (5): 597–607. doi:10.1086/500139. ISSN 1058-4838. PMID 16447103. Kritika študije v DOI: 10.1086/504431; avtorjev odgovor v DOI: 10.1086/504437.
Cottagnoud P; Gerber CM; Acosta F; Cottagnoud M; Neftel K; Täuber MG (2000). »Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model«. Journal of Antimicrobial Chemotherapy. 46 (6): 981–985. doi:10.1093/jac/46.6.981. ISSN 0305-7453. PMID 11102418.
Ntziora F; Falagas ME (2007). »Linezolid for the treatment of patients with central nervous system infection«. Annals of Pharmacotherapy. 41 (2): 296–308. doi:10.1345/aph.1H307. ISSN 1060-0280. PMID 17284501. Structured abstract with quality assessment available at DARE.
Tunkel A.R.; Hartman B.J.; Kaplan S.L.; in sod. (2004). »Practice guidelines for the management of bacterial meningitis«. Clinical Infectious Diseases. 39 (9): 1267–1284. doi:10.1086/425368. ISSN 1058-4838. PMID 15494903.
Naesens R; Ronsyn M; Druwé P; Denis O; Ieven M; Jeurissen A (2009). »Central nervous system invasion by community-acquired methicillin-resistant Staphylococcus aureus: case report and review of the literature«. Journal of Medical Microbiology. 58 (Pt 9): 1247–1251. doi:10.1099/jmm.0.011130-0. ISSN 0022-2615. PMID 19528145.
Wilcox MH; Tack KJ; Bouza E; in sod. (2009). »Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study«. Clinical Infectious Diseases. 48 (2): 203–212. doi:10.1086/595686. ISSN 1058-4838. PMID 19072714.
Metaxas EI; Falagas ME (2009). »Update on the safety of linezolid«. Expert Opinion on Drug Safety. 8 (4): 485–891. doi:10.1517/14740330903049706. ISSN 1474-0338. PMID 19538105.
Zabel LT; Worm S (2005). »Linezolid contributed to Clostridium difficile colitis with fatal outcome«. Infection. 33 (3): 155–7. doi:10.1007/s15010-005-4112-6. ISSN 0300-8126. PMID 15940418.
Peláez T; Alonso R; Pérez C; Alcalá L; Cuevas O; Bouza E (2002). »In vitro activity of linezolid against Clostridium difficile«. Antimicrobial Agents and Chemotherapy. 46 (5): 1617–1618. doi:10.1128/AAC.46.5.1617-1618.2002. ISSN 0066-4804. PMC 127182. PMID 11959617.
Lin Y-H; Wu V-C; Tsai I-J; in sod. (2006). »High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency«. International Journal of Antimicrobial Agents. 28 (4): 345–351. doi:10.1016/j.ijantimicag.2006.04.017. ISSN 0924-8579. PMID 16935472.
Spellberg B; Yoo T; Bayer AS (2004). »Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6«. Journal of Antimicrobial Chemotherapy. 54 (4): 832–5. doi:10.1093/jac/dkh405. ISSN 0305-7453. PMID 15317746.
Plachouras D; Giannitsioti E; Athanassia S; in sod. (2006). »No effect of pyridoxine on the incidence of myelosuppression during prolonged linezolid treatment«. Clinical Infectious Diseases. 43 (9): e89–91. doi:10.1086/508280. ISSN 1058-4838. PMID 17029128.
Narita M; Tsuji BT; Yu VL (2007). »Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome«. Pharmacotherapy. 27 (8): 1189–1197. doi:10.1592/phco.27.8.1189. ISSN 0277-0008. PMID 17655517.
Bressler AM; Zimmer SM; Gilmore JL; Somani J (2004). »Peripheral neuropathy associated with prolonged use of linezolid«. Lancet Infectious Diseases. 4 (8): 528–31. doi:10.1016/S1473-3099(04)01109-0. ISSN 1473-3099. PMID 15288827.
Chao CC; Sun HY; Chang YC; Hsieh ST (2008). »Painful neuropathy with skin denervation after prolonged use of linezolid«. Journal of Neurology, Neurosurgery & Psychiatry. 79 (1): 97–99. doi:10.1136/jnnp.2007.127910. ISSN 0022-3050. PMID 17766431.
Saijo T; Hayashi K; Yamada H; Wakakura M (2005). »Linezolid-induced optic neuropathy«. American Journal of Ophthalmology. 139 (6): 1114–1116. doi:10.1016/j.ajo.2004.11.047. ISSN 0002-9394. PMID 15953450.
Soriano A; Miró O; Mensa J (2005). »Mitochondrial toxicity associated with linezolid«. New England Journal of Medicine. 353 (21): 2305–6. doi:10.1056/NEJM200511243532123. ISSN 0028-4793. PMID 16306535.
Javaheri M; Khurana RN; O'hearn TM; Lai MM; Sadun AA (2007). »Linezolid-induced optic neuropathy: a mitochondrial disorder?«. British Journal of Ophthalmology. 91 (1): 111–115. doi:10.1136/bjo.2006.102541. ISSN 0007-1161. PMC 1857552. PMID 17179125.
McKee EE; Ferguson M; Bentley AT; Marks TA (2006). »Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones«. Antimicrobial Agents and Chemotherapy. 50 (6): 2042–2049. doi:10.1128/AAC.01411-05. ISSN 0066-4804. PMC 1479116. PMID 16723564.
Bishop E; Melvani S; Howden BP; Charles PG; Grayson ML (2006). »Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients«. Antimicrobial Agents and Chemotherapy. 50 (4): 1599–1602. doi:10.1128/AAC.50.4.1599-1602.2006. ISSN 0066-4804. PMC 1426936. PMID 16569895.
Lohray BB; Baskaran S; Rao BS; Reddy BY; Rao IN (1999). »A short synthesis of oxazolidinone derivatives linezolid and eperezolid: A new class of antibacterials«. Tetrahedron Letters. 40 (26): 4855–6. doi:10.1016/S0040-4039(99)00893-X.
Sisson TL; Jungbluth GL; Hopkins NK (2002). »Age and sex effects on the pharmacokinetics of linezolid«. European Journal of Clinical Pharmacology. 57 (11): 793–797. doi:10.1007/s00228-001-0380-y. ISSN 0031-6970. PMID 11868801.
Lovering AM; Le Floch R; Hovsepian L; in sod. (2009). »Pharmacokinetic evaluation of linezolid in patients with major thermal injuries«. Journal of Antimicrobial Chemotherapy. 63 (3): 553–9. doi:10.1093/jac/dkn541. ISSN 0305-7453. PMID 19153078.
Skripkin E; McConnell TS; DeVito J; in sod. (2008). »Rχ-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance«. Antimicrobial Agents and Chemotherapy. 52 (10): 3550–3557. doi:10.1128/AAC.01193-07. ISSN 0066-4804. PMC 2565890. PMID 18663023.
Colca JR; McDonald WG; Waldon DJ; in sod. (2003). »Cross-linking in the living cell locates the site of action of oxazolidinone antibiotics«. Journal of Biological Chemistry. 278 (24): 21972–21979. doi:10.1074/jbc.M302109200. ISSN 0021-9258. PMID 12690106. Arhivirano iz prvotnega spletišča dne 15. decembra 2005. Pridobljeno 2. oktobra 2010.
Ippolito JA; Kanyo ZF; Wang D; in sod. (2008). »Crystal structure of the oxazolidinone antibiotic linezolid bound to the 50S ribosomal subunit«. Journal of Medicinal Chemistry. 51 (12): 3353–3356. doi:10.1021/jm800379d. ISSN 0022-2623. PMID 18494460.
Wilson DN; Schluenzen F; Harms JM; Starosta AL; Connell SR; Fucini P (2008). »The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning«. Proceedings of the National Academy of Sciences. 105 (36): 13339–13344. doi:10.1073/pnas.0804276105. ISSN 0027-8424. PMC 2533191. PMID 18757750.^{[mrtva povezava]}
Tsiodras S; Gold HS; Sakoulas G; in sod. (2001). »Linezolid resistance in a clinical isolate of Staphylococcus aureus«. The Lancet. 358 (9277): 207–208. doi:10.1016/S0140-6736(01)05410-1. ISSN 0140-6736. PMID 11476839.
Jones RN; Kohno S; Ono Y; Ross JE; Yanagihara K (2009). »ZAAPS International Surveillance Program (2007) for linezolid resistance: results from 5591 Gram-positive clinical isolates in 23 countries«. Diagnostic Microbiology and Infectious Disease. 64 (2): 191–201. doi:10.1016/j.diagmicrobio.2009.03.001. ISSN 0732-8893. PMID 19500528.
Hope R; Livermore DM; Brick G; Lillie M; Reynolds R (2008). »Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06«. Journal of Antimicrobial Chemotherapy. 62 (Suppl 2): ii65–74. doi:10.1093/jac/dkn353. ISSN 0305-7453. PMID 18819981.
Auckland C; Teare L; Cooke F; in sod. (2002). »Linezolid-resistant enterococci: report of the first isolates in the United Kingdom«. Journal of Antimicrobial Chemotherapy. 50 (5): 743–746. doi:10.1093/jac/dkf246. ISSN 0305-7453. PMID 12407134.
Scheetz MH; Knechtel SA; Malczynski M; Postelnick MJ; Qi C (2008). »Increasing incidence of linezolid-intermediate or -resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumption«. Antimicrobial Agents and Chemotherapy. 52 (6): 2256–2259. doi:10.1128/AAC.00070-08. ISSN 0066-4804. PMC 2415807. PMID 18391028.
Schumacher A; Trittler R; Bohnert JA; Kümmerer K; Pagès JM; Kern WV (2007). »Intracellular accumulation of linezolid in Escherichia coli, Citrobacter freundii and Enterobacter aerogenes: role of enhanced efflux pump activity and inactivation«. Journal of Antimicrobial Chemotherapy. 59 (6): 1261–1264. doi:10.1093/jac/dkl380. ISSN 0305-7453. PMID 16971414.
Saager B; Rohde H; Timmerbeil BS; in sod. (2008). »Molecular characterisation of linezolid resistance in two vancomycin-resistant (VanB) Enterococcus faecium isolates using Pyrosequencing«. European Journal of Clinical Microbiology & Infectious Diseases. 27 (9): 873–878. doi:10.1007/s10096-008-0514-6. ISSN 0934-9723. PMID 18421487.
Besier S; Ludwig A; Zander J; Brade V; Wichelhaus TA (2008). »Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances«. Antimicrobial Agents and Chemotherapy. 52 (4): 1570–1572. doi:10.1128/AAC.01098-07. ISSN 0066-4804. PMC 2292563. PMID 18212098.
Feng J; Lupien A; Gingras H; in sod. (2009). »Genome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistance«. Genome Research. 19 (7): 1214–1223. doi:10.1101/gr.089342.108. ISSN 1088-9051. PMC 2704432. PMID 19351617.
Lincopan N; de Almeida LM; Elmor de Araújo MR; Mamizuka EM (2009). »Linezolid resistance in Staphylococcus epidermidis associated with a G2603T mutation in the 23S rRNA gene«. International Journal of Antimicrobial Agents. 34 (3): 281–282. doi:10.1016/j.ijantimicag.2009.02.023. ISSN 0924-8579. PMID 19376688.
Liakopoulos A; Neocleous C; Klapsa D; in sod. (2009). »A T2504A mutation in the 23S rRNA gene responsible for high-level resistance to linezolid of Staphylococcus epidermidis«. Journal of Antimicrobial Chemotherapy. 64 (1): 206–207. doi:10.1093/jac/dkp167. ISSN 0305-7453. PMID 19429927.
Lawrence KR; Adra M; Gillman PK (2006). »Serotonin toxicity associated with the use of linezolid: a review of postmarketing data«. Clinical Infectious Diseases. 42 (11): 1578–83. doi:10.1086/503839. ISSN 1058-4838. PMID 16652315.
Huang V; Gortney JS (2006). »Risk of serotonin syndrome with concomitant administration of linezolid and serotonin agonists«. Pharmacotherapy. 26 (12): 1784–93. doi:10.1592/phco.26.12.1784. ISSN 0277-0008. PMID 17125439.
Stalker DJ; Jungbluth GL (2003). »Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial«. Clinical Pharmacokinetics. 42 (13): 1129–1140. doi:10.2165/00003088-200342130-00004. ISSN 0312-5963. PMID 14531724.

dx.doi.org

Jaksic B; Martinelli G; Perez-Oteyza J; Hartman CS; Leonard LB; Tack KJ (2006). »Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer«. Clinical Infectious Diseases. 42 (5): 597–607. doi:10.1086/500139. ISSN 1058-4838. PMID 16447103. Kritika študije v DOI: 10.1086/504431; avtorjev odgovor v DOI: 10.1086/504437.

elsevier.es

Pigrau C; Almirante B (2009). »[Oxazolidinones, glycopeptides and cyclic lipopeptides]«. Enfermedades Infecciosas y Microbiología Clínica (v španščini). Zv. 27, št. 4. str. 236–46. doi:10.1016/j.eimc.2009.02.004. PMID 19406516.^{[mrtva povezava]}

espacenet.com

v3.espacenet.com

US patent 5837870^{[mrtva povezava]}, Pearlman BA, Perrault WR, Barbachyn MR, et al., "Process to prepare oxazolidinones", izdano dne 1997-03-28. Pridobljeno dne 2009-06-13.

europa.eu

emea.europa.eu

European Medicines Agency (2008). »CHP Assessment Report for Xarelto (EMEA/543519/2008)« (PDF). Pridobljeno 11. junija 2009.

fda.gov

»Drug Approval Package: Zyvox«. FDA Center for Drug Evaluation and Research. 20. november 2001. Arhivirano iz spletišča dne 10. januarja 2008. Pridobljeno 17. januarja 2009. Comprehensive review of the FDA approval process. Includes detailed reviews of the chemistry and pharmacology of linezolid, correspondence between the FDA and Pharmacia & Upjohn, and administrative documents.
»Linezolid (marketed as Zyvox) – Healthcare Professional Sheet«. U.S. Food and Drug Administration. 16. marec 2007. Pridobljeno 15. septembra 2010.

accessdata.fda.gov

Pfizer (20. junij 2008). »ZYVOX (linezolid) Label Information« (PDF). Pridobljeno 24. avgusta 2008.

hpa.org.uk

»Animal Bites and Pasteurella multocida: Information for Healthcare Staff«. Health Protection Agency. 5. avgust 2008. Arhivirano iz prvotnega spletišča dne 11. maja 2012. Pridobljeno 2. oktobra 2010. Pridobljeno 15. 5. 2009.

imm.ac.cn

Xu GY; Zhou Y; Xu MC (2006). »A convenient synthesis of antibacterial linezolid from (S)-glyceraldehyde acetonide« (PDF). Chinese Chemical Letters. 17 (3): 302–304. Arhivirano iz prvotnega spletišča (PDF) dne 7. maja 2006. Pridobljeno 2. oktobra 2010.

infezmed.it

Sabbatani S; Manfredi R; Frank G; Chiodo F (2005). »Linezolid in the treatment of severe central nervous system infections resistant to recommended antimicrobial compounds«. Le Infezioni in Medicina. 13 (2): 112–9. ISSN 1124-9390. PMID 16220032. Arhivirano iz prvotnega spletišča dne 22. julija 2011. Pridobljeno 2. oktobra 2010.

jbc.org

Colca JR; McDonald WG; Waldon DJ; in sod. (2003). »Cross-linking in the living cell locates the site of action of oxazolidinone antibiotics«. Journal of Biological Chemistry. 278 (24): 21972–21979. doi:10.1074/jbc.M302109200. ISSN 0021-9258. PMID 12690106. Arhivirano iz prvotnega spletišča dne 15. decembra 2005. Pridobljeno 2. oktobra 2010.

medicalnewstoday.com

»Trius Completes Enrollment In Phase 2 Clinical Trial Evaluating Torezolid (TR-701) In Patients With Complicated Skin And Skin Structure Infections« (tiskovna objava). 27. januar 2009. Arhivirano iz prvotnega spletišča dne 14. februarja 2009. Pridobljeno 17. maja 2009.

medicines.org.uk

emc.medicines.org.uk

»Zyvox 600 mg Film-Coated Tablets, 100 mg/5 ml Granules for Oral Suspension, 2 mg/ml Solution for Infusion – Povzetek glavnih značilnosti zdravila (SPC)«. electronic Medicines Compendium. 24. junij 2009. Arhivirano iz prvotnega spletišča dne 6. avgusta 2012. Pridobljeno 3. julija 2009.

medscape.com

[Avtorji niso navedeni] (2001). »Linezolid«. Drugs & Therapy Perspectives. 17 (9): 1–6. Arhivirano iz prvotnega spletišča dne 21. maja 2013. Pridobljeno 2. oktobra 2010.
Waknine, Yael (5. september 2009). »FDA Safety Changes: Mirena, Zyvox, Orencia«. Medscape. Pridobljeno 6. septembra 2008.

merck.com

Lexi-Comp (Avgust 2008). »Linezolid«. The Merck Manual Professional. Pridobljeno 14. maja 2009.

nih.gov

pubmed.ncbi.nlm.nih.gov

Grau S; Rubio-Terrés C (2008). »Pharmacoeconomics of linezolid«. Expert Opinion on Pharmacotherapy. 9 (6): 987–1000. doi:10.1517/14656566.9.6.987. ISSN 1465-6566. PMID 18377341.
Moellering RC (2003). »Linezolid: the first oxazolidinone antimicrobial« (PDF). Annals of Internal Medicine. 138 (2): 135–142. ISSN 0003-4819. PMID 12529096.
Slee AM; Wuonola MA; McRipley RJ; in sod. (1987). »Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721« (PDF). Antimicrobial Agents and Chemotherapy. 31 (11): 1791–1797. ISSN 0066-4804. PMC 175041. PMID 3435127. Arhivirano iz prvotnega spletišča (PDF) dne 11. junija 2011. Pridobljeno 2. oktobra 2010.
Livermore DM (2000). »Quinupristin/dalfopristin and linezolid: where, when, which and whether to use?«. Journal of Antimicrobial Chemotherapy. 46 (3): 347–50. doi:10.1093/jac/46.3.347. ISSN 0305-7453. PMID 10980159.
Barbachyn MR; Ford CW (2003). »Oxazolidinone structure-activity relationships leading to linezolid«. Angewandte Chemie (International Edition in English). 42 (18): 2010–2023. doi:10.1002/anie.200200528. ISSN 1433-7851. PMID 12746812.
French G (2003). »Safety and tolerability of linezolid«. Journal of Antimicrobial Chemotherapy. 51 (Suppl 2): ii45–53. doi:10.1093/jac/dkg253. ISSN 0305-7453. PMID 12730142. Review. Includes extensive discussion of the hematological adverse effects of linezolid.
Ford CW; Zurenko GE; Barbachyn MR (2001). »The discovery of linezolid, the first oxazolidinone antibacterial agent«. Current Drug Targets – Infectious Disorders. 1 (2): 181–199. doi:10.2174/1568005014606099. ISSN 1568-0053. PMID 12455414.
Irinoda K; Nomura S; Hashimoto M (2002). »Antimicrobial and clinical effect of linezolid (ZYVOX), new class of synthetic antibacterial drug«. Nippon Yakurigaku Zasshi (v japonščini). 120 (4): 245–252. doi:10.1254/fpj.120.245. ISSN 0015-5691. PMID 12425150.
Karlowsky JA; Kelly LJ; Critchley IA; Jones ME; Thornsberry C; Sahm DF (2002). »Determining Linezolid's baseline in vitro activity in Canada using gram-positive clinical isolates collected prior to its national release«. Antimicrobial Agents and Chemotherapy. 46 (6): 1989–1992. doi:10.1128/AAC.46.6.1989-1992.2002. ISSN 0066-4804. PMC 127260. PMID 12019122.
Livermore DM; Mushtaq S; Warner M; Woodford N (2009). »Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci«. Journal of Antimicrobial Chemotherapy. 63 (4): 713–715. doi:10.1093/jac/dkp002. ISSN 0305-7453. PMID 19164418.
Howe RA; Wootton M; Noel AR; Bowker KE; Walsh TR; MacGowan AP (2003). »Activity of AZD2563, a novel oxazolidinone, against Staphylococcus aureus strains with reduced susceptibility to vancomycin or linezolid«. Antimicrobial Agents and Chemotherapy. 47 (11): 3651–3652. doi:10.1128/AAC.47.11.3651-3652.2003. ISSN 0066-4804. PMC 253812. PMID 14576139.
Kalia V; Miglani R; Purnapatre KP; in sod. (2009). »Mode of action of Ranbezolid against staphylococci and structural modeling studies of its interaction with ribosomes«. Antimicrobial Agents and Chemotherapy. 53 (4): 1427–1433. doi:10.1128/AAC.00887-08. ISSN 0066-4804. PMC 2663096. PMID 19075051.
Jones RN; Stilwell MG; Hogan PA; Sheehan DJ (2007). »Activity of linezolid against 3,251 strains of uncommonly isolated gram-positive organisms: report from the SENTRY Antimicrobial Surveillance Program«. Antimicrobial Agents and Chemotherapy. 51 (4): 1491–1493. doi:10.1128/AAC.01496-06. PMC 1855453. PMID 17210770.
Jodlowski TZ; Melnychuk I; Conry J (2007). »Linezolid for the treatment of Nocardia spp. infections«. Annals of Pharmacotherapy. 41 (10): 1694–1699. doi:10.1345/aph.1K196. ISSN 1060-0280. PMID 17785610.
Herrmann DJ; Peppard WJ; Ledeboer NA; Theesfeld ML; Weigelt JA; Buechel BJ (2008). »Linezolid for the treatment of drug-resistant infections«. Expert Review of Anti-infective Therapy. 6 (6): 825–848. doi:10.1586/14787210.6.6.825. ISSN 1478-7210. PMID 19053895.
Sabbatani S; Manfredi R; Frank G; Chiodo F (2005). »Linezolid in the treatment of severe central nervous system infections resistant to recommended antimicrobial compounds«. Le Infezioni in Medicina. 13 (2): 112–9. ISSN 1124-9390. PMID 16220032. Arhivirano iz prvotnega spletišča dne 22. julija 2011. Pridobljeno 2. oktobra 2010.
Geisler WM; Malhotra U; Stamm WE (2001). »Pneumonia and sepsis due to fluoroquinolone-resistant Capnocytophaga gingivalis after autologous stem cell transplantation«. Bone Marrow Transplantation. 28 (12): 1171–1173. doi:10.1038/sj.bmt.1703288. ISSN 0268-3369. PMID 11803363.
Wilson AP; Cepeda JA; Hayman S; Whitehouse T; Singer M; Bellingan G (2006). »In vitro susceptibility of Gram-positive pathogens to linezolid and teicoplanin and effect on outcome in critically ill patients«. Journal of Antimicrobial Chemotherapy. 58 (2): 470–3. doi:10.1093/jac/dkl233. ISSN 0305-7453. PMID 16735420.
Falagas ME; Siempos II; Vardakas KZ (2008). »Linezolid versus glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials«. Lancet Infectious Diseases. Zv. 8, št. 1. str. 53–66. doi:10.1016/S1473-3099(07)70312-2. ISSN 1473-3099. PMID 18156089. Strukturiran izvleček z oceno kakovosti dostopen v DARE.
Tascini C; Gemignani G; Doria R; in sod. (2009). »Linezolid treatment for gram-positive infections: a retrospective comparison with teicoplanin«. Journal of Chemotherapy (Florence, Italy). Zv. 21, št. 3. str. 311–316. ISSN 1120-009X. PMID 19567352.
Chow I; Lemos EV; Einarson TR (2008). »Management and prevention of diabetic foot ulcers and infections: a health economic review«. PharmacoEconomics. Zv. 26, št. 12. str. 1019–1035. doi:10.2165/0019053-200826120-00005. ISSN 1170-7690. PMID 19014203.
Lipsky BA; Itani K; Norden C (2004). »Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate«. Clinical Infectious Diseases. Zv. 38, št. 1. str. 17–24. doi:10.1086/380449. ISSN 1058-4838. PMID 14679443.
Pigrau C; Almirante B (2009). »[Oxazolidinones, glycopeptides and cyclic lipopeptides]«. Enfermedades Infecciosas y Microbiología Clínica (v španščini). Zv. 27, št. 4. str. 236–46. doi:10.1016/j.eimc.2009.02.004. PMID 19406516.^{[mrtva povezava]}
Vardakas KZ; Horianopoulou M; Falagas ME (2008). »Factors associated with treatment failure in patients with diabetic foot infections: An analysis of data from randomized controlled trials«. Diabetes Research and Clinical Practice. Zv. 80, št. 3. str. 344–351. doi:10.1016/j.diabres.2008.01.009. ISSN 0168-8227. PMID 18291550.
Mandell LA; Wunderink RG; Anzueto A; in sod. (2007). »Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults«. Clinical Infectious Diseases. 44 (Suppl 2): S27–72. doi:10.1086/511159. ISSN 1058-4838. PMID 17278083.
American Thoracic Society; Infectious Diseases Society of America (2005). »Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia«. American Journal of Respiratory and Critical Care Medicine. 171 (4): 388–416. doi:10.1164/rccm.200405-644ST. ISSN 1073-449X. PMID 15699079.
Koya D; Shibuya K; Kikkawa R; Haneda M (2004). »Successful recovery of infective endocarditis-induced rapidly progressive glomerulonephritis by steroid therapy combined with antibiotics: a case report«. BMC Nephrology. 5 (1): 18. doi:10.1186/1471-2369-5-18. PMC 544880. PMID 15610562.
Pankey GA; Sabath LD (2004). »Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections«. Clinical Infectious Diseases. 38 (6): 864–870. doi:10.1086/381972. ISSN 1058-4838. PMID 14999632.
Falagas ME; Manta KG; Ntziora F; Vardakas KZ (2006). »Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence«. Journal of Antimicrobial Chemotherapy. 58 (2): 273–280. doi:10.1093/jac/dkl219. ISSN 0305-7453. PMID 16735427.
Babcock HM; Ritchie DJ; Christiansen E; Starlin R; Little R; Stanley S (2001). »Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid«. Clinical Infectious Diseases. 32 (9): 1373–1375. doi:10.1086/319986. ISSN 1058-4838. PMID 11303275.
Ang JY; Lua JL; Turner DR; Asmar BI (2003). »Vancomycin-resistant Enterococcus faecium endocarditis in a premature infant successfully treated with linezolid«. The Pediatric Infectious Disease Journal. 22 (12): 1101–1103. doi:10.1097/01.inf.0000101784.83146.0c. ISSN 0891-3668. PMID 14688576.
Archuleta S; Murphy B; Keller MJ (2004). »Successful treatment of vancomycin-resistant Enterococcus faecium endocarditis with linezolid in a renal transplant recipient with human immunodeficiency virus infection«. Transplant Infectious Disease. 6 (3): 117–119. doi:10.1111/j.1399-3062.2004.00059.x. ISSN 1398-2273. PMID 15569227.
Zimmer SM; Caliendo AM; Thigpen MC; Somani J (2003). »Failure of linezolid treatment for enterococcal endocarditis«. Clinical Infectious Diseases. 37 (3): e29–30. doi:10.1086/375877. ISSN 1058-4838. PMID 12884185.
Tsigrelis C; Singh KV; Coutinho TD; Murray BE; Baddour LM (2007). »Vancomycin-resistant Enterococcus faecalis endocarditis: linezolid failure and strain characterization of virulence factors«. Journal of Clinical Microbiology. 45 (2): 631–635. doi:10.1128/JCM.02188-06. ISSN 0095-1137. PMC 1829077. PMID 17182759.
Berdal JE; Eskesen A (2008). »Short-term success, but long-term treatment failure with linezolid for enterococcal endocarditis«. Scandinavian Journal of Infectious Diseases. 40 (9): 765–766. doi:10.1080/00365540802087209. ISSN 0036-5548. PMID 18609208.
Falagas ME; Siempos II; Papagelopoulos PJ; Vardakas KZ (2007). »Linezolid for the treatment of adults with bone and joint infections«. International Journal of Antimicrobial Agents. 29 (3): 233–239. doi:10.1016/j.ijantimicag.2006.08.030. ISSN 0924-8579. PMID 17204407. Review.
Bassetti M; Vitale F; Melica G; in sod. (2005). »Linezolid in the treatment of Gram-positive prosthetic joint infections«. Journal of Antimicrobial Chemotherapy. 55 (3): 387–390. doi:10.1093/jac/dki016. ISSN 0305-7453. PMID 15705640.
Aneziokoro CO; Cannon JP; Pachucki CT; Lentino JR (2005). »The effectiveness and safety of oral linezolid for the primary and secondary treatment of osteomyelitis«. Journal of Chemotherapy (Florence, Italy). 17 (6): 643–650. ISSN 1120-009X. PMID 16433195.
Senneville E; Legout L; Valette M; in sod. (2006). »Effectiveness and tolerability of prolonged linezolid treatment for chronic osteomyelitis: a retrospective study«. Clinical Therapeutics. 28 (8): 1155–1163. doi:10.1016/j.clinthera.2006.08.001. ISSN 0149-2918. PMID 16982292.
Rao N; Hamilton CW (2007). »Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series«. Diagnostic Microbiology and Infectious Disease. 59 (2): 173–179. doi:10.1016/j.diagmicrobio.2007.04.006. ISSN 0732-8893. PMID 17574788.
Papadopoulos A; Plachouras D; Giannitsioti E; Poulakou G; Giamarellou H; Kanellakopoulou K (2009). »Efficacy and tolerability of linezolid in chronic osteomyelitis and prosthetic joint infections: a case-control study«. Journal of Chemotherapy (Florence, Italy). 21 (2): 165–9. ISSN 1120-009X. PMID 19423469.
von der Lippe B; Sandven P; Brubakk O (2006). »Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)—a report of ten cases«. Journal of Infection. 52 (2): 92–96. doi:10.1016/j.jinf.2005.04.007. ISSN 0163-4453. PMID 15907341.
Park IN; Hong SB; Oh YM; in sod. (2006). »Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis«. Journal of Antimicrobial Chemotherapy. 58 (3): 701–704. doi:10.1093/jac/dkl298. ISSN 0305-7453. PMID 16857689.
Fortún J; Martín-Dávila P; Navas E; in sod. (2005). »Linezolid for the treatment of multidrug-resistant tuberculosis«. Journal of Antimicrobial Chemotherapy. 56 (1): 180–5. doi:10.1093/jac/dki148. ISSN 0305-7453. PMID 15911549.
Jaksic B; Martinelli G; Perez-Oteyza J; Hartman CS; Leonard LB; Tack KJ (2006). »Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer«. Clinical Infectious Diseases. 42 (5): 597–607. doi:10.1086/500139. ISSN 1058-4838. PMID 16447103. Kritika študije v DOI: 10.1086/504431; avtorjev odgovor v DOI: 10.1086/504437.
Cottagnoud P; Gerber CM; Acosta F; Cottagnoud M; Neftel K; Täuber MG (2000). »Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model«. Journal of Antimicrobial Chemotherapy. 46 (6): 981–985. doi:10.1093/jac/46.6.981. ISSN 0305-7453. PMID 11102418.
Ntziora F; Falagas ME (2007). »Linezolid for the treatment of patients with central nervous system infection«. Annals of Pharmacotherapy. 41 (2): 296–308. doi:10.1345/aph.1H307. ISSN 1060-0280. PMID 17284501. Structured abstract with quality assessment available at DARE.
Tunkel A.R.; Hartman B.J.; Kaplan S.L.; in sod. (2004). »Practice guidelines for the management of bacterial meningitis«. Clinical Infectious Diseases. 39 (9): 1267–1284. doi:10.1086/425368. ISSN 1058-4838. PMID 15494903.
Naesens R; Ronsyn M; Druwé P; Denis O; Ieven M; Jeurissen A (2009). »Central nervous system invasion by community-acquired methicillin-resistant Staphylococcus aureus: case report and review of the literature«. Journal of Medical Microbiology. 58 (Pt 9): 1247–1251. doi:10.1099/jmm.0.011130-0. ISSN 0022-2615. PMID 19528145.
Wilcox MH; Tack KJ; Bouza E; in sod. (2009). »Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study«. Clinical Infectious Diseases. 48 (2): 203–212. doi:10.1086/595686. ISSN 1058-4838. PMID 19072714.
Metaxas EI; Falagas ME (2009). »Update on the safety of linezolid«. Expert Opinion on Drug Safety. 8 (4): 485–891. doi:10.1517/14740330903049706. ISSN 1474-0338. PMID 19538105.
Zabel LT; Worm S (2005). »Linezolid contributed to Clostridium difficile colitis with fatal outcome«. Infection. 33 (3): 155–7. doi:10.1007/s15010-005-4112-6. ISSN 0300-8126. PMID 15940418.
Peláez T; Alonso R; Pérez C; Alcalá L; Cuevas O; Bouza E (2002). »In vitro activity of linezolid against Clostridium difficile«. Antimicrobial Agents and Chemotherapy. 46 (5): 1617–1618. doi:10.1128/AAC.46.5.1617-1618.2002. ISSN 0066-4804. PMC 127182. PMID 11959617.
Lin Y-H; Wu V-C; Tsai I-J; in sod. (2006). »High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency«. International Journal of Antimicrobial Agents. 28 (4): 345–351. doi:10.1016/j.ijantimicag.2006.04.017. ISSN 0924-8579. PMID 16935472.
Spellberg B; Yoo T; Bayer AS (2004). »Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6«. Journal of Antimicrobial Chemotherapy. 54 (4): 832–5. doi:10.1093/jac/dkh405. ISSN 0305-7453. PMID 15317746.
Plachouras D; Giannitsioti E; Athanassia S; in sod. (2006). »No effect of pyridoxine on the incidence of myelosuppression during prolonged linezolid treatment«. Clinical Infectious Diseases. 43 (9): e89–91. doi:10.1086/508280. ISSN 1058-4838. PMID 17029128.
Narita M; Tsuji BT; Yu VL (2007). »Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome«. Pharmacotherapy. 27 (8): 1189–1197. doi:10.1592/phco.27.8.1189. ISSN 0277-0008. PMID 17655517.
Bressler AM; Zimmer SM; Gilmore JL; Somani J (2004). »Peripheral neuropathy associated with prolonged use of linezolid«. Lancet Infectious Diseases. 4 (8): 528–31. doi:10.1016/S1473-3099(04)01109-0. ISSN 1473-3099. PMID 15288827.
Chao CC; Sun HY; Chang YC; Hsieh ST (2008). »Painful neuropathy with skin denervation after prolonged use of linezolid«. Journal of Neurology, Neurosurgery & Psychiatry. 79 (1): 97–99. doi:10.1136/jnnp.2007.127910. ISSN 0022-3050. PMID 17766431.
Saijo T; Hayashi K; Yamada H; Wakakura M (2005). »Linezolid-induced optic neuropathy«. American Journal of Ophthalmology. 139 (6): 1114–1116. doi:10.1016/j.ajo.2004.11.047. ISSN 0002-9394. PMID 15953450.
Soriano A; Miró O; Mensa J (2005). »Mitochondrial toxicity associated with linezolid«. New England Journal of Medicine. 353 (21): 2305–6. doi:10.1056/NEJM200511243532123. ISSN 0028-4793. PMID 16306535.
Javaheri M; Khurana RN; O'hearn TM; Lai MM; Sadun AA (2007). »Linezolid-induced optic neuropathy: a mitochondrial disorder?«. British Journal of Ophthalmology. 91 (1): 111–115. doi:10.1136/bjo.2006.102541. ISSN 0007-1161. PMC 1857552. PMID 17179125.
McKee EE; Ferguson M; Bentley AT; Marks TA (2006). »Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones«. Antimicrobial Agents and Chemotherapy. 50 (6): 2042–2049. doi:10.1128/AAC.01411-05. ISSN 0066-4804. PMC 1479116. PMID 16723564.
Bishop E; Melvani S; Howden BP; Charles PG; Grayson ML (2006). »Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients«. Antimicrobial Agents and Chemotherapy. 50 (4): 1599–1602. doi:10.1128/AAC.50.4.1599-1602.2006. ISSN 0066-4804. PMC 1426936. PMID 16569895.
Ament PW; Jamshed N; Horne JP (2002). »Linezolid: its role in the treatment of gram-positive, drug-resistant bacterial infections«. American Family Physician. 65 (4): 663–670. ISSN 0002-838X. PMID 11871684. Arhivirano iz prvotnega spletišča dne 24. julija 2008. Pridobljeno 2. oktobra 2010.
Slatter JG; Stalker DJ; Feenstra KL; in sod. (1. avgust 2001). »Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [¹⁴C]linezolid to healthy human subjects«. Drug Metabolism and Disposition. 29 (8): 1136–1145. ISSN 0090-9556. PMID 11454733. Arhivirano iz prvotnega spletišča dne 7. januarja 2009. Pridobljeno 2. oktobra 2010.
Sisson TL; Jungbluth GL; Hopkins NK (2002). »Age and sex effects on the pharmacokinetics of linezolid«. European Journal of Clinical Pharmacology. 57 (11): 793–797. doi:10.1007/s00228-001-0380-y. ISSN 0031-6970. PMID 11868801.
Lovering AM; Le Floch R; Hovsepian L; in sod. (2009). »Pharmacokinetic evaluation of linezolid in patients with major thermal injuries«. Journal of Antimicrobial Chemotherapy. 63 (3): 553–9. doi:10.1093/jac/dkn541. ISSN 0305-7453. PMID 19153078.
Skripkin E; McConnell TS; DeVito J; in sod. (2008). »Rχ-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance«. Antimicrobial Agents and Chemotherapy. 52 (10): 3550–3557. doi:10.1128/AAC.01193-07. ISSN 0066-4804. PMC 2565890. PMID 18663023.
Swaney SM; Aoki H; Ganoza MC; Shinabarger DL (1. december 1998). »The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria«. Antimicrobial Agents and Chemotherapy. 42 (12): 3251–3255. ISSN 0066-4804. PMC 106030. PMID 9835522. Arhivirano iz prvotnega spletišča dne 17. januarja 2011. Pridobljeno 2. oktobra 2010.
Colca JR; McDonald WG; Waldon DJ; in sod. (2003). »Cross-linking in the living cell locates the site of action of oxazolidinone antibiotics«. Journal of Biological Chemistry. 278 (24): 21972–21979. doi:10.1074/jbc.M302109200. ISSN 0021-9258. PMID 12690106. Arhivirano iz prvotnega spletišča dne 15. decembra 2005. Pridobljeno 2. oktobra 2010.
Ippolito JA; Kanyo ZF; Wang D; in sod. (2008). »Crystal structure of the oxazolidinone antibiotic linezolid bound to the 50S ribosomal subunit«. Journal of Medicinal Chemistry. 51 (12): 3353–3356. doi:10.1021/jm800379d. ISSN 0022-2623. PMID 18494460.
Wilson DN; Schluenzen F; Harms JM; Starosta AL; Connell SR; Fucini P (2008). »The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning«. Proceedings of the National Academy of Sciences. 105 (36): 13339–13344. doi:10.1073/pnas.0804276105. ISSN 0027-8424. PMC 2533191. PMID 18757750.^{[mrtva povezava]}
Tsiodras S; Gold HS; Sakoulas G; in sod. (2001). »Linezolid resistance in a clinical isolate of Staphylococcus aureus«. The Lancet. 358 (9277): 207–208. doi:10.1016/S0140-6736(01)05410-1. ISSN 0140-6736. PMID 11476839.
Jones RN; Kohno S; Ono Y; Ross JE; Yanagihara K (2009). »ZAAPS International Surveillance Program (2007) for linezolid resistance: results from 5591 Gram-positive clinical isolates in 23 countries«. Diagnostic Microbiology and Infectious Disease. 64 (2): 191–201. doi:10.1016/j.diagmicrobio.2009.03.001. ISSN 0732-8893. PMID 19500528.
Hope R; Livermore DM; Brick G; Lillie M; Reynolds R (2008). »Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06«. Journal of Antimicrobial Chemotherapy. 62 (Suppl 2): ii65–74. doi:10.1093/jac/dkn353. ISSN 0305-7453. PMID 18819981.
Auckland C; Teare L; Cooke F; in sod. (2002). »Linezolid-resistant enterococci: report of the first isolates in the United Kingdom«. Journal of Antimicrobial Chemotherapy. 50 (5): 743–746. doi:10.1093/jac/dkf246. ISSN 0305-7453. PMID 12407134.
Scheetz MH; Knechtel SA; Malczynski M; Postelnick MJ; Qi C (2008). »Increasing incidence of linezolid-intermediate or -resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumption«. Antimicrobial Agents and Chemotherapy. 52 (6): 2256–2259. doi:10.1128/AAC.00070-08. ISSN 0066-4804. PMC 2415807. PMID 18391028.
Schumacher A; Trittler R; Bohnert JA; Kümmerer K; Pagès JM; Kern WV (2007). »Intracellular accumulation of linezolid in Escherichia coli, Citrobacter freundii and Enterobacter aerogenes: role of enhanced efflux pump activity and inactivation«. Journal of Antimicrobial Chemotherapy. 59 (6): 1261–1264. doi:10.1093/jac/dkl380. ISSN 0305-7453. PMID 16971414.
Saager B; Rohde H; Timmerbeil BS; in sod. (2008). »Molecular characterisation of linezolid resistance in two vancomycin-resistant (VanB) Enterococcus faecium isolates using Pyrosequencing«. European Journal of Clinical Microbiology & Infectious Diseases. 27 (9): 873–878. doi:10.1007/s10096-008-0514-6. ISSN 0934-9723. PMID 18421487.
Besier S; Ludwig A; Zander J; Brade V; Wichelhaus TA (2008). »Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances«. Antimicrobial Agents and Chemotherapy. 52 (4): 1570–1572. doi:10.1128/AAC.01098-07. ISSN 0066-4804. PMC 2292563. PMID 18212098.
Feng J; Lupien A; Gingras H; in sod. (2009). »Genome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistance«. Genome Research. 19 (7): 1214–1223. doi:10.1101/gr.089342.108. ISSN 1088-9051. PMC 2704432. PMID 19351617.
Lincopan N; de Almeida LM; Elmor de Araújo MR; Mamizuka EM (2009). »Linezolid resistance in Staphylococcus epidermidis associated with a G2603T mutation in the 23S rRNA gene«. International Journal of Antimicrobial Agents. 34 (3): 281–282. doi:10.1016/j.ijantimicag.2009.02.023. ISSN 0924-8579. PMID 19376688.
Liakopoulos A; Neocleous C; Klapsa D; in sod. (2009). »A T2504A mutation in the 23S rRNA gene responsible for high-level resistance to linezolid of Staphylococcus epidermidis«. Journal of Antimicrobial Chemotherapy. 64 (1): 206–207. doi:10.1093/jac/dkp167. ISSN 0305-7453. PMID 19429927.
Lawrence KR; Adra M; Gillman PK (2006). »Serotonin toxicity associated with the use of linezolid: a review of postmarketing data«. Clinical Infectious Diseases. 42 (11): 1578–83. doi:10.1086/503839. ISSN 1058-4838. PMID 16652315.
Huang V; Gortney JS (2006). »Risk of serotonin syndrome with concomitant administration of linezolid and serotonin agonists«. Pharmacotherapy. 26 (12): 1784–93. doi:10.1592/phco.26.12.1784. ISSN 0277-0008. PMID 17125439.
Stalker DJ; Jungbluth GL (2003). »Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial«. Clinical Pharmacokinetics. 42 (13): 1129–1140. doi:10.2165/00003088-200342130-00004. ISSN 0312-5963. PMID 14531724.

ncbi.nlm.nih.gov

Slee AM; Wuonola MA; McRipley RJ; in sod. (1987). »Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721« (PDF). Antimicrobial Agents and Chemotherapy. 31 (11): 1791–1797. ISSN 0066-4804. PMC 175041. PMID 3435127. Arhivirano iz prvotnega spletišča (PDF) dne 11. junija 2011. Pridobljeno 2. oktobra 2010.
Karlowsky JA; Kelly LJ; Critchley IA; Jones ME; Thornsberry C; Sahm DF (2002). »Determining Linezolid's baseline in vitro activity in Canada using gram-positive clinical isolates collected prior to its national release«. Antimicrobial Agents and Chemotherapy. 46 (6): 1989–1992. doi:10.1128/AAC.46.6.1989-1992.2002. ISSN 0066-4804. PMC 127260. PMID 12019122.
Howe RA; Wootton M; Noel AR; Bowker KE; Walsh TR; MacGowan AP (2003). »Activity of AZD2563, a novel oxazolidinone, against Staphylococcus aureus strains with reduced susceptibility to vancomycin or linezolid«. Antimicrobial Agents and Chemotherapy. 47 (11): 3651–3652. doi:10.1128/AAC.47.11.3651-3652.2003. ISSN 0066-4804. PMC 253812. PMID 14576139.
Kalia V; Miglani R; Purnapatre KP; in sod. (2009). »Mode of action of Ranbezolid against staphylococci and structural modeling studies of its interaction with ribosomes«. Antimicrobial Agents and Chemotherapy. 53 (4): 1427–1433. doi:10.1128/AAC.00887-08. ISSN 0066-4804. PMC 2663096. PMID 19075051.
Jones RN; Stilwell MG; Hogan PA; Sheehan DJ (2007). »Activity of linezolid against 3,251 strains of uncommonly isolated gram-positive organisms: report from the SENTRY Antimicrobial Surveillance Program«. Antimicrobial Agents and Chemotherapy. 51 (4): 1491–1493. doi:10.1128/AAC.01496-06. PMC 1855453. PMID 17210770.
Koya D; Shibuya K; Kikkawa R; Haneda M (2004). »Successful recovery of infective endocarditis-induced rapidly progressive glomerulonephritis by steroid therapy combined with antibiotics: a case report«. BMC Nephrology. 5 (1): 18. doi:10.1186/1471-2369-5-18. PMC 544880. PMID 15610562.
Tsigrelis C; Singh KV; Coutinho TD; Murray BE; Baddour LM (2007). »Vancomycin-resistant Enterococcus faecalis endocarditis: linezolid failure and strain characterization of virulence factors«. Journal of Clinical Microbiology. 45 (2): 631–635. doi:10.1128/JCM.02188-06. ISSN 0095-1137. PMC 1829077. PMID 17182759.
Peláez T; Alonso R; Pérez C; Alcalá L; Cuevas O; Bouza E (2002). »In vitro activity of linezolid against Clostridium difficile«. Antimicrobial Agents and Chemotherapy. 46 (5): 1617–1618. doi:10.1128/AAC.46.5.1617-1618.2002. ISSN 0066-4804. PMC 127182. PMID 11959617.
Javaheri M; Khurana RN; O'hearn TM; Lai MM; Sadun AA (2007). »Linezolid-induced optic neuropathy: a mitochondrial disorder?«. British Journal of Ophthalmology. 91 (1): 111–115. doi:10.1136/bjo.2006.102541. ISSN 0007-1161. PMC 1857552. PMID 17179125.
McKee EE; Ferguson M; Bentley AT; Marks TA (2006). »Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones«. Antimicrobial Agents and Chemotherapy. 50 (6): 2042–2049. doi:10.1128/AAC.01411-05. ISSN 0066-4804. PMC 1479116. PMID 16723564.
Bishop E; Melvani S; Howden BP; Charles PG; Grayson ML (2006). »Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients«. Antimicrobial Agents and Chemotherapy. 50 (4): 1599–1602. doi:10.1128/AAC.50.4.1599-1602.2006. ISSN 0066-4804. PMC 1426936. PMID 16569895.
Skripkin E; McConnell TS; DeVito J; in sod. (2008). »Rχ-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance«. Antimicrobial Agents and Chemotherapy. 52 (10): 3550–3557. doi:10.1128/AAC.01193-07. ISSN 0066-4804. PMC 2565890. PMID 18663023.
Swaney SM; Aoki H; Ganoza MC; Shinabarger DL (1. december 1998). »The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria«. Antimicrobial Agents and Chemotherapy. 42 (12): 3251–3255. ISSN 0066-4804. PMC 106030. PMID 9835522. Arhivirano iz prvotnega spletišča dne 17. januarja 2011. Pridobljeno 2. oktobra 2010.
Wilson DN; Schluenzen F; Harms JM; Starosta AL; Connell SR; Fucini P (2008). »The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning«. Proceedings of the National Academy of Sciences. 105 (36): 13339–13344. doi:10.1073/pnas.0804276105. ISSN 0027-8424. PMC 2533191. PMID 18757750.^{[mrtva povezava]}
Scheetz MH; Knechtel SA; Malczynski M; Postelnick MJ; Qi C (2008). »Increasing incidence of linezolid-intermediate or -resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumption«. Antimicrobial Agents and Chemotherapy. 52 (6): 2256–2259. doi:10.1128/AAC.00070-08. ISSN 0066-4804. PMC 2415807. PMID 18391028.
Besier S; Ludwig A; Zander J; Brade V; Wichelhaus TA (2008). »Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances«. Antimicrobial Agents and Chemotherapy. 52 (4): 1570–1572. doi:10.1128/AAC.01098-07. ISSN 0066-4804. PMC 2292563. PMID 18212098.
Feng J; Lupien A; Gingras H; in sod. (2009). »Genome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistance«. Genome Research. 19 (7): 1214–1223. doi:10.1101/gr.089342.108. ISSN 1088-9051. PMC 2704432. PMID 19351617.

oxfordjournals.org

jac.oxfordjournals.org

Livermore DM (2000). »Quinupristin/dalfopristin and linezolid: where, when, which and whether to use?«. Journal of Antimicrobial Chemotherapy. 46 (3): 347–50. doi:10.1093/jac/46.3.347. ISSN 0305-7453. PMID 10980159.
French G (2003). »Safety and tolerability of linezolid«. Journal of Antimicrobial Chemotherapy. 51 (Suppl 2): ii45–53. doi:10.1093/jac/dkg253. ISSN 0305-7453. PMID 12730142. Review. Includes extensive discussion of the hematological adverse effects of linezolid.
Wilson AP; Cepeda JA; Hayman S; Whitehouse T; Singer M; Bellingan G (2006). »In vitro susceptibility of Gram-positive pathogens to linezolid and teicoplanin and effect on outcome in critically ill patients«. Journal of Antimicrobial Chemotherapy. 58 (2): 470–3. doi:10.1093/jac/dkl233. ISSN 0305-7453. PMID 16735420.
Falagas ME; Manta KG; Ntziora F; Vardakas KZ (2006). »Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence«. Journal of Antimicrobial Chemotherapy. 58 (2): 273–280. doi:10.1093/jac/dkl219. ISSN 0305-7453. PMID 16735427.
Bassetti M; Vitale F; Melica G; in sod. (2005). »Linezolid in the treatment of Gram-positive prosthetic joint infections«. Journal of Antimicrobial Chemotherapy. 55 (3): 387–390. doi:10.1093/jac/dki016. ISSN 0305-7453. PMID 15705640.
Park IN; Hong SB; Oh YM; in sod. (2006). »Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis«. Journal of Antimicrobial Chemotherapy. 58 (3): 701–704. doi:10.1093/jac/dkl298. ISSN 0305-7453. PMID 16857689.
Fortún J; Martín-Dávila P; Navas E; in sod. (2005). »Linezolid for the treatment of multidrug-resistant tuberculosis«. Journal of Antimicrobial Chemotherapy. 56 (1): 180–5. doi:10.1093/jac/dki148. ISSN 0305-7453. PMID 15911549.
Cottagnoud P; Gerber CM; Acosta F; Cottagnoud M; Neftel K; Täuber MG (2000). »Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model«. Journal of Antimicrobial Chemotherapy. 46 (6): 981–985. doi:10.1093/jac/46.6.981. ISSN 0305-7453. PMID 11102418.
Spellberg B; Yoo T; Bayer AS (2004). »Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6«. Journal of Antimicrobial Chemotherapy. 54 (4): 832–5. doi:10.1093/jac/dkh405. ISSN 0305-7453. PMID 15317746.
Hope R; Livermore DM; Brick G; Lillie M; Reynolds R (2008). »Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06«. Journal of Antimicrobial Chemotherapy. 62 (Suppl 2): ii65–74. doi:10.1093/jac/dkn353. ISSN 0305-7453. PMID 18819981.
Auckland C; Teare L; Cooke F; in sod. (2002). »Linezolid-resistant enterococci: report of the first isolates in the United Kingdom«. Journal of Antimicrobial Chemotherapy. 50 (5): 743–746. doi:10.1093/jac/dkf246. ISSN 0305-7453. PMID 12407134.
Schumacher A; Trittler R; Bohnert JA; Kümmerer K; Pagès JM; Kern WV (2007). »Intracellular accumulation of linezolid in Escherichia coli, Citrobacter freundii and Enterobacter aerogenes: role of enhanced efflux pump activity and inactivation«. Journal of Antimicrobial Chemotherapy. 59 (6): 1261–1264. doi:10.1093/jac/dkl380. ISSN 0305-7453. PMID 16971414.

pnas.org

Wilson DN; Schluenzen F; Harms JM; Starosta AL; Connell SR; Fucini P (2008). »The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning«. Proceedings of the National Academy of Sciences. 105 (36): 13339–13344. doi:10.1073/pnas.0804276105. ISSN 0027-8424. PMC 2533191. PMID 18757750.^{[mrtva povezava]}

prnewswire.ca

»Pharmacia Corporation Reports 17% Increase In Second-Quarter Earnings-Per-Share Driven By 61% Increase In Pharmaceutical Earnings« (tiskovna objava). 25. junij 2001. Pridobljeno 19. maja 2009.

rib-x.com

»Rx 1741«. Rib-X Pharmaceuticals. 2009. Arhivirano iz prvotnega spletišča dne 26. februarja 2009. Pridobljeno 17. maja 2009.

theage.com.au

Wroe, David (28. februar 2002). »An antibiotic to fight immune bugs«. The Age. Pridobljeno 16. maja 2009.

virginia.edu

healthsystem.virginia.edu

Buck ML (2003). »Linezolid use for resistant Gram-positive infections in children« (PDF). Pediatric Pharmacotherapy. 9 (6). Arhivirano iz prvotnega spletišča (PDF) dne 5. junija 2011. Pridobljeno 8. junija 2009.

web.archive.org

Slee AM; Wuonola MA; McRipley RJ; in sod. (1987). »Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721« (PDF). Antimicrobial Agents and Chemotherapy. 31 (11): 1791–1797. ISSN 0066-4804. PMC 175041. PMID 3435127. Arhivirano iz prvotnega spletišča (PDF) dne 11. junija 2011. Pridobljeno 2. oktobra 2010.
»Drug Approval Package: Zyvox«. FDA Center for Drug Evaluation and Research. 20. november 2001. Arhivirano iz spletišča dne 10. januarja 2008. Pridobljeno 17. januarja 2009. Comprehensive review of the FDA approval process. Includes detailed reviews of the chemistry and pharmacology of linezolid, correspondence between the FDA and Pharmacia & Upjohn, and administrative documents.
»Zyvox 600 mg Film-Coated Tablets, 100 mg/5 ml Granules for Oral Suspension, 2 mg/ml Solution for Infusion – Povzetek glavnih značilnosti zdravila (SPC)«. electronic Medicines Compendium. 24. junij 2009. Arhivirano iz prvotnega spletišča dne 6. avgusta 2012. Pridobljeno 3. julija 2009.
»Trius Completes Enrollment In Phase 2 Clinical Trial Evaluating Torezolid (TR-701) In Patients With Complicated Skin And Skin Structure Infections« (tiskovna objava). 27. januar 2009. Arhivirano iz prvotnega spletišča dne 14. februarja 2009. Pridobljeno 17. maja 2009.
»Rx 1741«. Rib-X Pharmaceuticals. 2009. Arhivirano iz prvotnega spletišča dne 26. februarja 2009. Pridobljeno 17. maja 2009.
[Avtorji niso navedeni] (2001). »Linezolid«. Drugs & Therapy Perspectives. 17 (9): 1–6. Arhivirano iz prvotnega spletišča dne 21. maja 2013. Pridobljeno 2. oktobra 2010.
»Animal Bites and Pasteurella multocida: Information for Healthcare Staff«. Health Protection Agency. 5. avgust 2008. Arhivirano iz prvotnega spletišča dne 11. maja 2012. Pridobljeno 2. oktobra 2010. Pridobljeno 15. 5. 2009.
Sabbatani S; Manfredi R; Frank G; Chiodo F (2005). »Linezolid in the treatment of severe central nervous system infections resistant to recommended antimicrobial compounds«. Le Infezioni in Medicina. 13 (2): 112–9. ISSN 1124-9390. PMID 16220032. Arhivirano iz prvotnega spletišča dne 22. julija 2011. Pridobljeno 2. oktobra 2010.
BTS Pneumonia Guidelines Committee (30. april 2004). »BTS guidelines for the management of community acquired pneumonia in adults – 2004 update« (PDF). British Thoracic Society. Arhivirano iz prvotnega spletišča (PDF) dne 21. septembra 2008. Pridobljeno 30. junija 2009.
http://lsm1.amebis.si/lsmeds/novPogoj.aspx Arhivirano 2011-02-11 na Wayback Machine., vpogled: 18. 10. 2010.
Xu GY; Zhou Y; Xu MC (2006). »A convenient synthesis of antibacterial linezolid from (S)-glyceraldehyde acetonide« (PDF). Chinese Chemical Letters. 17 (3): 302–304. Arhivirano iz prvotnega spletišča (PDF) dne 7. maja 2006. Pridobljeno 2. oktobra 2010.
Kaiser CR; Cunico W; Pinheiro AC; Oliveira AG; Peralta MA; Souza MV (2007). »Oxazolidinones: a new class of compounds against tuberculosis« (PDF). Revista Brasileira de Farmácia (v portugalščini). 88 (2): 83–88. Arhivirano (PDF) iz spletišča dne 31. oktobra 2008. Pridobljeno 2. oktobra 2010.
Perrault WR, Keeler JB, Snyder WC, et al. (June 25, 2008). "Convergent green synthesis of linezolid (Zyvox)" Arhivirano 2011-07-28 na Wayback Machine., in 12th Annual Green Chemistry and Engineering Conference, 24.–26. junij 2008, New York, NY. Pridobljeno 8. 6. 2009.
Ament PW; Jamshed N; Horne JP (2002). »Linezolid: its role in the treatment of gram-positive, drug-resistant bacterial infections«. American Family Physician. 65 (4): 663–670. ISSN 0002-838X. PMID 11871684. Arhivirano iz prvotnega spletišča dne 24. julija 2008. Pridobljeno 2. oktobra 2010.
Slatter JG; Stalker DJ; Feenstra KL; in sod. (1. avgust 2001). »Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [¹⁴C]linezolid to healthy human subjects«. Drug Metabolism and Disposition. 29 (8): 1136–1145. ISSN 0090-9556. PMID 11454733. Arhivirano iz prvotnega spletišča dne 7. januarja 2009. Pridobljeno 2. oktobra 2010.
Buck ML (2003). »Linezolid use for resistant Gram-positive infections in children« (PDF). Pediatric Pharmacotherapy. 9 (6). Arhivirano iz prvotnega spletišča (PDF) dne 5. junija 2011. Pridobljeno 8. junija 2009.
Swaney SM; Aoki H; Ganoza MC; Shinabarger DL (1. december 1998). »The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria«. Antimicrobial Agents and Chemotherapy. 42 (12): 3251–3255. ISSN 0066-4804. PMC 106030. PMID 9835522. Arhivirano iz prvotnega spletišča dne 17. januarja 2011. Pridobljeno 2. oktobra 2010.
Colca JR; McDonald WG; Waldon DJ; in sod. (2003). »Cross-linking in the living cell locates the site of action of oxazolidinone antibiotics«. Journal of Biological Chemistry. 278 (24): 21972–21979. doi:10.1074/jbc.M302109200. ISSN 0021-9258. PMID 12690106. Arhivirano iz prvotnega spletišča dne 15. decembra 2005. Pridobljeno 2. oktobra 2010.

worldcat.org

Grau S; Rubio-Terrés C (2008). »Pharmacoeconomics of linezolid«. Expert Opinion on Pharmacotherapy. 9 (6): 987–1000. doi:10.1517/14656566.9.6.987. ISSN 1465-6566. PMID 18377341.
Moellering RC (2003). »Linezolid: the first oxazolidinone antimicrobial« (PDF). Annals of Internal Medicine. 138 (2): 135–142. ISSN 0003-4819. PMID 12529096.
Slee AM; Wuonola MA; McRipley RJ; in sod. (1987). »Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721« (PDF). Antimicrobial Agents and Chemotherapy. 31 (11): 1791–1797. ISSN 0066-4804. PMC 175041. PMID 3435127. Arhivirano iz prvotnega spletišča (PDF) dne 11. junija 2011. Pridobljeno 2. oktobra 2010.
Livermore DM (2000). »Quinupristin/dalfopristin and linezolid: where, when, which and whether to use?«. Journal of Antimicrobial Chemotherapy. 46 (3): 347–50. doi:10.1093/jac/46.3.347. ISSN 0305-7453. PMID 10980159.
Barbachyn MR; Ford CW (2003). »Oxazolidinone structure-activity relationships leading to linezolid«. Angewandte Chemie (International Edition in English). 42 (18): 2010–2023. doi:10.1002/anie.200200528. ISSN 1433-7851. PMID 12746812.
French G (2003). »Safety and tolerability of linezolid«. Journal of Antimicrobial Chemotherapy. 51 (Suppl 2): ii45–53. doi:10.1093/jac/dkg253. ISSN 0305-7453. PMID 12730142. Review. Includes extensive discussion of the hematological adverse effects of linezolid.
Ford CW; Zurenko GE; Barbachyn MR (2001). »The discovery of linezolid, the first oxazolidinone antibacterial agent«. Current Drug Targets – Infectious Disorders. 1 (2): 181–199. doi:10.2174/1568005014606099. ISSN 1568-0053. PMID 12455414.
Irinoda K; Nomura S; Hashimoto M (2002). »Antimicrobial and clinical effect of linezolid (ZYVOX), new class of synthetic antibacterial drug«. Nippon Yakurigaku Zasshi (v japonščini). 120 (4): 245–252. doi:10.1254/fpj.120.245. ISSN 0015-5691. PMID 12425150.
Karlowsky JA; Kelly LJ; Critchley IA; Jones ME; Thornsberry C; Sahm DF (2002). »Determining Linezolid's baseline in vitro activity in Canada using gram-positive clinical isolates collected prior to its national release«. Antimicrobial Agents and Chemotherapy. 46 (6): 1989–1992. doi:10.1128/AAC.46.6.1989-1992.2002. ISSN 0066-4804. PMC 127260. PMID 12019122.
Livermore DM; Mushtaq S; Warner M; Woodford N (2009). »Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci«. Journal of Antimicrobial Chemotherapy. 63 (4): 713–715. doi:10.1093/jac/dkp002. ISSN 0305-7453. PMID 19164418.
Howe RA; Wootton M; Noel AR; Bowker KE; Walsh TR; MacGowan AP (2003). »Activity of AZD2563, a novel oxazolidinone, against Staphylococcus aureus strains with reduced susceptibility to vancomycin or linezolid«. Antimicrobial Agents and Chemotherapy. 47 (11): 3651–3652. doi:10.1128/AAC.47.11.3651-3652.2003. ISSN 0066-4804. PMC 253812. PMID 14576139.
Kalia V; Miglani R; Purnapatre KP; in sod. (2009). »Mode of action of Ranbezolid against staphylococci and structural modeling studies of its interaction with ribosomes«. Antimicrobial Agents and Chemotherapy. 53 (4): 1427–1433. doi:10.1128/AAC.00887-08. ISSN 0066-4804. PMC 2663096. PMID 19075051.
Jodlowski TZ; Melnychuk I; Conry J (2007). »Linezolid for the treatment of Nocardia spp. infections«. Annals of Pharmacotherapy. 41 (10): 1694–1699. doi:10.1345/aph.1K196. ISSN 1060-0280. PMID 17785610.
Herrmann DJ; Peppard WJ; Ledeboer NA; Theesfeld ML; Weigelt JA; Buechel BJ (2008). »Linezolid for the treatment of drug-resistant infections«. Expert Review of Anti-infective Therapy. 6 (6): 825–848. doi:10.1586/14787210.6.6.825. ISSN 1478-7210. PMID 19053895.
Sabbatani S; Manfredi R; Frank G; Chiodo F (2005). »Linezolid in the treatment of severe central nervous system infections resistant to recommended antimicrobial compounds«. Le Infezioni in Medicina. 13 (2): 112–9. ISSN 1124-9390. PMID 16220032. Arhivirano iz prvotnega spletišča dne 22. julija 2011. Pridobljeno 2. oktobra 2010.
Geisler WM; Malhotra U; Stamm WE (2001). »Pneumonia and sepsis due to fluoroquinolone-resistant Capnocytophaga gingivalis after autologous stem cell transplantation«. Bone Marrow Transplantation. 28 (12): 1171–1173. doi:10.1038/sj.bmt.1703288. ISSN 0268-3369. PMID 11803363.
Wilson AP; Cepeda JA; Hayman S; Whitehouse T; Singer M; Bellingan G (2006). »In vitro susceptibility of Gram-positive pathogens to linezolid and teicoplanin and effect on outcome in critically ill patients«. Journal of Antimicrobial Chemotherapy. 58 (2): 470–3. doi:10.1093/jac/dkl233. ISSN 0305-7453. PMID 16735420.
Falagas ME; Siempos II; Vardakas KZ (2008). »Linezolid versus glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials«. Lancet Infectious Diseases. Zv. 8, št. 1. str. 53–66. doi:10.1016/S1473-3099(07)70312-2. ISSN 1473-3099. PMID 18156089. Strukturiran izvleček z oceno kakovosti dostopen v DARE.
Tascini C; Gemignani G; Doria R; in sod. (2009). »Linezolid treatment for gram-positive infections: a retrospective comparison with teicoplanin«. Journal of Chemotherapy (Florence, Italy). Zv. 21, št. 3. str. 311–316. ISSN 1120-009X. PMID 19567352.
Chow I; Lemos EV; Einarson TR (2008). »Management and prevention of diabetic foot ulcers and infections: a health economic review«. PharmacoEconomics. Zv. 26, št. 12. str. 1019–1035. doi:10.2165/0019053-200826120-00005. ISSN 1170-7690. PMID 19014203.
Lipsky BA; Itani K; Norden C (2004). »Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate«. Clinical Infectious Diseases. Zv. 38, št. 1. str. 17–24. doi:10.1086/380449. ISSN 1058-4838. PMID 14679443.
Vardakas KZ; Horianopoulou M; Falagas ME (2008). »Factors associated with treatment failure in patients with diabetic foot infections: An analysis of data from randomized controlled trials«. Diabetes Research and Clinical Practice. Zv. 80, št. 3. str. 344–351. doi:10.1016/j.diabres.2008.01.009. ISSN 0168-8227. PMID 18291550.
Mandell LA; Wunderink RG; Anzueto A; in sod. (2007). »Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults«. Clinical Infectious Diseases. 44 (Suppl 2): S27–72. doi:10.1086/511159. ISSN 1058-4838. PMID 17278083.
American Thoracic Society; Infectious Diseases Society of America (2005). »Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia«. American Journal of Respiratory and Critical Care Medicine. 171 (4): 388–416. doi:10.1164/rccm.200405-644ST. ISSN 1073-449X. PMID 15699079.
Pankey GA; Sabath LD (2004). »Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections«. Clinical Infectious Diseases. 38 (6): 864–870. doi:10.1086/381972. ISSN 1058-4838. PMID 14999632.
Falagas ME; Manta KG; Ntziora F; Vardakas KZ (2006). »Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence«. Journal of Antimicrobial Chemotherapy. 58 (2): 273–280. doi:10.1093/jac/dkl219. ISSN 0305-7453. PMID 16735427.
Babcock HM; Ritchie DJ; Christiansen E; Starlin R; Little R; Stanley S (2001). »Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid«. Clinical Infectious Diseases. 32 (9): 1373–1375. doi:10.1086/319986. ISSN 1058-4838. PMID 11303275.
Ang JY; Lua JL; Turner DR; Asmar BI (2003). »Vancomycin-resistant Enterococcus faecium endocarditis in a premature infant successfully treated with linezolid«. The Pediatric Infectious Disease Journal. 22 (12): 1101–1103. doi:10.1097/01.inf.0000101784.83146.0c. ISSN 0891-3668. PMID 14688576.
Archuleta S; Murphy B; Keller MJ (2004). »Successful treatment of vancomycin-resistant Enterococcus faecium endocarditis with linezolid in a renal transplant recipient with human immunodeficiency virus infection«. Transplant Infectious Disease. 6 (3): 117–119. doi:10.1111/j.1399-3062.2004.00059.x. ISSN 1398-2273. PMID 15569227.
Zimmer SM; Caliendo AM; Thigpen MC; Somani J (2003). »Failure of linezolid treatment for enterococcal endocarditis«. Clinical Infectious Diseases. 37 (3): e29–30. doi:10.1086/375877. ISSN 1058-4838. PMID 12884185.
Tsigrelis C; Singh KV; Coutinho TD; Murray BE; Baddour LM (2007). »Vancomycin-resistant Enterococcus faecalis endocarditis: linezolid failure and strain characterization of virulence factors«. Journal of Clinical Microbiology. 45 (2): 631–635. doi:10.1128/JCM.02188-06. ISSN 0095-1137. PMC 1829077. PMID 17182759.
Berdal JE; Eskesen A (2008). »Short-term success, but long-term treatment failure with linezolid for enterococcal endocarditis«. Scandinavian Journal of Infectious Diseases. 40 (9): 765–766. doi:10.1080/00365540802087209. ISSN 0036-5548. PMID 18609208.
Falagas ME; Siempos II; Papagelopoulos PJ; Vardakas KZ (2007). »Linezolid for the treatment of adults with bone and joint infections«. International Journal of Antimicrobial Agents. 29 (3): 233–239. doi:10.1016/j.ijantimicag.2006.08.030. ISSN 0924-8579. PMID 17204407. Review.
Bassetti M; Vitale F; Melica G; in sod. (2005). »Linezolid in the treatment of Gram-positive prosthetic joint infections«. Journal of Antimicrobial Chemotherapy. 55 (3): 387–390. doi:10.1093/jac/dki016. ISSN 0305-7453. PMID 15705640.
Aneziokoro CO; Cannon JP; Pachucki CT; Lentino JR (2005). »The effectiveness and safety of oral linezolid for the primary and secondary treatment of osteomyelitis«. Journal of Chemotherapy (Florence, Italy). 17 (6): 643–650. ISSN 1120-009X. PMID 16433195.
Senneville E; Legout L; Valette M; in sod. (2006). »Effectiveness and tolerability of prolonged linezolid treatment for chronic osteomyelitis: a retrospective study«. Clinical Therapeutics. 28 (8): 1155–1163. doi:10.1016/j.clinthera.2006.08.001. ISSN 0149-2918. PMID 16982292.
Rao N; Hamilton CW (2007). »Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series«. Diagnostic Microbiology and Infectious Disease. 59 (2): 173–179. doi:10.1016/j.diagmicrobio.2007.04.006. ISSN 0732-8893. PMID 17574788.
Papadopoulos A; Plachouras D; Giannitsioti E; Poulakou G; Giamarellou H; Kanellakopoulou K (2009). »Efficacy and tolerability of linezolid in chronic osteomyelitis and prosthetic joint infections: a case-control study«. Journal of Chemotherapy (Florence, Italy). 21 (2): 165–9. ISSN 1120-009X. PMID 19423469.
von der Lippe B; Sandven P; Brubakk O (2006). »Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)—a report of ten cases«. Journal of Infection. 52 (2): 92–96. doi:10.1016/j.jinf.2005.04.007. ISSN 0163-4453. PMID 15907341.
Park IN; Hong SB; Oh YM; in sod. (2006). »Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis«. Journal of Antimicrobial Chemotherapy. 58 (3): 701–704. doi:10.1093/jac/dkl298. ISSN 0305-7453. PMID 16857689.
Fortún J; Martín-Dávila P; Navas E; in sod. (2005). »Linezolid for the treatment of multidrug-resistant tuberculosis«. Journal of Antimicrobial Chemotherapy. 56 (1): 180–5. doi:10.1093/jac/dki148. ISSN 0305-7453. PMID 15911549.
Jaksic B; Martinelli G; Perez-Oteyza J; Hartman CS; Leonard LB; Tack KJ (2006). »Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer«. Clinical Infectious Diseases. 42 (5): 597–607. doi:10.1086/500139. ISSN 1058-4838. PMID 16447103. Kritika študije v DOI: 10.1086/504431; avtorjev odgovor v DOI: 10.1086/504437.
Cottagnoud P; Gerber CM; Acosta F; Cottagnoud M; Neftel K; Täuber MG (2000). »Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model«. Journal of Antimicrobial Chemotherapy. 46 (6): 981–985. doi:10.1093/jac/46.6.981. ISSN 0305-7453. PMID 11102418.
Ntziora F; Falagas ME (2007). »Linezolid for the treatment of patients with central nervous system infection«. Annals of Pharmacotherapy. 41 (2): 296–308. doi:10.1345/aph.1H307. ISSN 1060-0280. PMID 17284501. Structured abstract with quality assessment available at DARE.
Tunkel A.R.; Hartman B.J.; Kaplan S.L.; in sod. (2004). »Practice guidelines for the management of bacterial meningitis«. Clinical Infectious Diseases. 39 (9): 1267–1284. doi:10.1086/425368. ISSN 1058-4838. PMID 15494903.
Naesens R; Ronsyn M; Druwé P; Denis O; Ieven M; Jeurissen A (2009). »Central nervous system invasion by community-acquired methicillin-resistant Staphylococcus aureus: case report and review of the literature«. Journal of Medical Microbiology. 58 (Pt 9): 1247–1251. doi:10.1099/jmm.0.011130-0. ISSN 0022-2615. PMID 19528145.
Wilcox MH; Tack KJ; Bouza E; in sod. (2009). »Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study«. Clinical Infectious Diseases. 48 (2): 203–212. doi:10.1086/595686. ISSN 1058-4838. PMID 19072714.
Metaxas EI; Falagas ME (2009). »Update on the safety of linezolid«. Expert Opinion on Drug Safety. 8 (4): 485–891. doi:10.1517/14740330903049706. ISSN 1474-0338. PMID 19538105.
Zabel LT; Worm S (2005). »Linezolid contributed to Clostridium difficile colitis with fatal outcome«. Infection. 33 (3): 155–7. doi:10.1007/s15010-005-4112-6. ISSN 0300-8126. PMID 15940418.
Peláez T; Alonso R; Pérez C; Alcalá L; Cuevas O; Bouza E (2002). »In vitro activity of linezolid against Clostridium difficile«. Antimicrobial Agents and Chemotherapy. 46 (5): 1617–1618. doi:10.1128/AAC.46.5.1617-1618.2002. ISSN 0066-4804. PMC 127182. PMID 11959617.
Lin Y-H; Wu V-C; Tsai I-J; in sod. (2006). »High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency«. International Journal of Antimicrobial Agents. 28 (4): 345–351. doi:10.1016/j.ijantimicag.2006.04.017. ISSN 0924-8579. PMID 16935472.
Spellberg B; Yoo T; Bayer AS (2004). »Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6«. Journal of Antimicrobial Chemotherapy. 54 (4): 832–5. doi:10.1093/jac/dkh405. ISSN 0305-7453. PMID 15317746.
Plachouras D; Giannitsioti E; Athanassia S; in sod. (2006). »No effect of pyridoxine on the incidence of myelosuppression during prolonged linezolid treatment«. Clinical Infectious Diseases. 43 (9): e89–91. doi:10.1086/508280. ISSN 1058-4838. PMID 17029128.
Narita M; Tsuji BT; Yu VL (2007). »Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome«. Pharmacotherapy. 27 (8): 1189–1197. doi:10.1592/phco.27.8.1189. ISSN 0277-0008. PMID 17655517.
Bressler AM; Zimmer SM; Gilmore JL; Somani J (2004). »Peripheral neuropathy associated with prolonged use of linezolid«. Lancet Infectious Diseases. 4 (8): 528–31. doi:10.1016/S1473-3099(04)01109-0. ISSN 1473-3099. PMID 15288827.
Chao CC; Sun HY; Chang YC; Hsieh ST (2008). »Painful neuropathy with skin denervation after prolonged use of linezolid«. Journal of Neurology, Neurosurgery & Psychiatry. 79 (1): 97–99. doi:10.1136/jnnp.2007.127910. ISSN 0022-3050. PMID 17766431.
Saijo T; Hayashi K; Yamada H; Wakakura M (2005). »Linezolid-induced optic neuropathy«. American Journal of Ophthalmology. 139 (6): 1114–1116. doi:10.1016/j.ajo.2004.11.047. ISSN 0002-9394. PMID 15953450.
Soriano A; Miró O; Mensa J (2005). »Mitochondrial toxicity associated with linezolid«. New England Journal of Medicine. 353 (21): 2305–6. doi:10.1056/NEJM200511243532123. ISSN 0028-4793. PMID 16306535.
Javaheri M; Khurana RN; O'hearn TM; Lai MM; Sadun AA (2007). »Linezolid-induced optic neuropathy: a mitochondrial disorder?«. British Journal of Ophthalmology. 91 (1): 111–115. doi:10.1136/bjo.2006.102541. ISSN 0007-1161. PMC 1857552. PMID 17179125.
McKee EE; Ferguson M; Bentley AT; Marks TA (2006). »Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones«. Antimicrobial Agents and Chemotherapy. 50 (6): 2042–2049. doi:10.1128/AAC.01411-05. ISSN 0066-4804. PMC 1479116. PMID 16723564.
Bishop E; Melvani S; Howden BP; Charles PG; Grayson ML (2006). »Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients«. Antimicrobial Agents and Chemotherapy. 50 (4): 1599–1602. doi:10.1128/AAC.50.4.1599-1602.2006. ISSN 0066-4804. PMC 1426936. PMID 16569895.
Ament PW; Jamshed N; Horne JP (2002). »Linezolid: its role in the treatment of gram-positive, drug-resistant bacterial infections«. American Family Physician. 65 (4): 663–670. ISSN 0002-838X. PMID 11871684. Arhivirano iz prvotnega spletišča dne 24. julija 2008. Pridobljeno 2. oktobra 2010.
Slatter JG; Stalker DJ; Feenstra KL; in sod. (1. avgust 2001). »Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [¹⁴C]linezolid to healthy human subjects«. Drug Metabolism and Disposition. 29 (8): 1136–1145. ISSN 0090-9556. PMID 11454733. Arhivirano iz prvotnega spletišča dne 7. januarja 2009. Pridobljeno 2. oktobra 2010.
Sisson TL; Jungbluth GL; Hopkins NK (2002). »Age and sex effects on the pharmacokinetics of linezolid«. European Journal of Clinical Pharmacology. 57 (11): 793–797. doi:10.1007/s00228-001-0380-y. ISSN 0031-6970. PMID 11868801.
Lovering AM; Le Floch R; Hovsepian L; in sod. (2009). »Pharmacokinetic evaluation of linezolid in patients with major thermal injuries«. Journal of Antimicrobial Chemotherapy. 63 (3): 553–9. doi:10.1093/jac/dkn541. ISSN 0305-7453. PMID 19153078.
Skripkin E; McConnell TS; DeVito J; in sod. (2008). »Rχ-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance«. Antimicrobial Agents and Chemotherapy. 52 (10): 3550–3557. doi:10.1128/AAC.01193-07. ISSN 0066-4804. PMC 2565890. PMID 18663023.
Swaney SM; Aoki H; Ganoza MC; Shinabarger DL (1. december 1998). »The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria«. Antimicrobial Agents and Chemotherapy. 42 (12): 3251–3255. ISSN 0066-4804. PMC 106030. PMID 9835522. Arhivirano iz prvotnega spletišča dne 17. januarja 2011. Pridobljeno 2. oktobra 2010.
Colca JR; McDonald WG; Waldon DJ; in sod. (2003). »Cross-linking in the living cell locates the site of action of oxazolidinone antibiotics«. Journal of Biological Chemistry. 278 (24): 21972–21979. doi:10.1074/jbc.M302109200. ISSN 0021-9258. PMID 12690106. Arhivirano iz prvotnega spletišča dne 15. decembra 2005. Pridobljeno 2. oktobra 2010.
Ippolito JA; Kanyo ZF; Wang D; in sod. (2008). »Crystal structure of the oxazolidinone antibiotic linezolid bound to the 50S ribosomal subunit«. Journal of Medicinal Chemistry. 51 (12): 3353–3356. doi:10.1021/jm800379d. ISSN 0022-2623. PMID 18494460.
Wilson DN; Schluenzen F; Harms JM; Starosta AL; Connell SR; Fucini P (2008). »The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning«. Proceedings of the National Academy of Sciences. 105 (36): 13339–13344. doi:10.1073/pnas.0804276105. ISSN 0027-8424. PMC 2533191. PMID 18757750.^{[mrtva povezava]}
Tsiodras S; Gold HS; Sakoulas G; in sod. (2001). »Linezolid resistance in a clinical isolate of Staphylococcus aureus«. The Lancet. 358 (9277): 207–208. doi:10.1016/S0140-6736(01)05410-1. ISSN 0140-6736. PMID 11476839.
Jones RN; Kohno S; Ono Y; Ross JE; Yanagihara K (2009). »ZAAPS International Surveillance Program (2007) for linezolid resistance: results from 5591 Gram-positive clinical isolates in 23 countries«. Diagnostic Microbiology and Infectious Disease. 64 (2): 191–201. doi:10.1016/j.diagmicrobio.2009.03.001. ISSN 0732-8893. PMID 19500528.
Hope R; Livermore DM; Brick G; Lillie M; Reynolds R (2008). »Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06«. Journal of Antimicrobial Chemotherapy. 62 (Suppl 2): ii65–74. doi:10.1093/jac/dkn353. ISSN 0305-7453. PMID 18819981.
Auckland C; Teare L; Cooke F; in sod. (2002). »Linezolid-resistant enterococci: report of the first isolates in the United Kingdom«. Journal of Antimicrobial Chemotherapy. 50 (5): 743–746. doi:10.1093/jac/dkf246. ISSN 0305-7453. PMID 12407134.
Scheetz MH; Knechtel SA; Malczynski M; Postelnick MJ; Qi C (2008). »Increasing incidence of linezolid-intermediate or -resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumption«. Antimicrobial Agents and Chemotherapy. 52 (6): 2256–2259. doi:10.1128/AAC.00070-08. ISSN 0066-4804. PMC 2415807. PMID 18391028.
Schumacher A; Trittler R; Bohnert JA; Kümmerer K; Pagès JM; Kern WV (2007). »Intracellular accumulation of linezolid in Escherichia coli, Citrobacter freundii and Enterobacter aerogenes: role of enhanced efflux pump activity and inactivation«. Journal of Antimicrobial Chemotherapy. 59 (6): 1261–1264. doi:10.1093/jac/dkl380. ISSN 0305-7453. PMID 16971414.
Saager B; Rohde H; Timmerbeil BS; in sod. (2008). »Molecular characterisation of linezolid resistance in two vancomycin-resistant (VanB) Enterococcus faecium isolates using Pyrosequencing«. European Journal of Clinical Microbiology & Infectious Diseases. 27 (9): 873–878. doi:10.1007/s10096-008-0514-6. ISSN 0934-9723. PMID 18421487.
Besier S; Ludwig A; Zander J; Brade V; Wichelhaus TA (2008). »Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances«. Antimicrobial Agents and Chemotherapy. 52 (4): 1570–1572. doi:10.1128/AAC.01098-07. ISSN 0066-4804. PMC 2292563. PMID 18212098.
Feng J; Lupien A; Gingras H; in sod. (2009). »Genome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistance«. Genome Research. 19 (7): 1214–1223. doi:10.1101/gr.089342.108. ISSN 1088-9051. PMC 2704432. PMID 19351617.
Lincopan N; de Almeida LM; Elmor de Araújo MR; Mamizuka EM (2009). »Linezolid resistance in Staphylococcus epidermidis associated with a G2603T mutation in the 23S rRNA gene«. International Journal of Antimicrobial Agents. 34 (3): 281–282. doi:10.1016/j.ijantimicag.2009.02.023. ISSN 0924-8579. PMID 19376688.
Liakopoulos A; Neocleous C; Klapsa D; in sod. (2009). »A T2504A mutation in the 23S rRNA gene responsible for high-level resistance to linezolid of Staphylococcus epidermidis«. Journal of Antimicrobial Chemotherapy. 64 (1): 206–207. doi:10.1093/jac/dkp167. ISSN 0305-7453. PMID 19429927.
Lawrence KR; Adra M; Gillman PK (2006). »Serotonin toxicity associated with the use of linezolid: a review of postmarketing data«. Clinical Infectious Diseases. 42 (11): 1578–83. doi:10.1086/503839. ISSN 1058-4838. PMID 16652315.
Huang V; Gortney JS (2006). »Risk of serotonin syndrome with concomitant administration of linezolid and serotonin agonists«. Pharmacotherapy. 26 (12): 1784–93. doi:10.1592/phco.26.12.1784. ISSN 0277-0008. PMID 17125439.
Stalker DJ; Jungbluth GL (2003). »Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial«. Clinical Pharmacokinetics. 42 (13): 1129–1140. doi:10.2165/00003088-200342130-00004. ISSN 0312-5963. PMID 14531724.

york.ac.uk

crd.york.ac.uk

Falagas ME; Siempos II; Vardakas KZ (2008). »Linezolid versus glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials«. Lancet Infectious Diseases. Zv. 8, št. 1. str. 53–66. doi:10.1016/S1473-3099(07)70312-2. ISSN 1473-3099. PMID 18156089. Strukturiran izvleček z oceno kakovosti dostopen v DARE.
Ntziora F; Falagas ME (2007). »Linezolid for the treatment of patients with central nervous system infection«. Annals of Pharmacotherapy. 41 (2): 296–308. doi:10.1345/aph.1H307. ISSN 1060-0280. PMID 17284501. Structured abstract with quality assessment available at DARE.